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Abstract 
Procedural sedation and analgesia (PSA) is performed by a variety of non-anaesthesiologists in 
numerous hospital settings. PSA guidelines have been formulated by a number of 
organisations in order to standardise practice and improve patient safety. Despite this it was 
uncertain whether PSA practitioners were aware of and used these guidelines, and whether 
the recommended equipment and drugs required for the safe delivery of PSA are available. 
The purpose of this research was to assess the demographic profile of non-anaesthesiologist 
PSA providers at Chris Hani Baragwanath Academic Hospital (CHBAH), their awareness of the 
South African Society of Anaesthesiologists (SASA) Sedation Guidelines 2010 and their level of 
comfort when performing PSA. An audit of available equipment and drugs in PSA settings 
outside the operating theatre was also done.  
The study revealed a gap in guideline knowledge, with respondents scoring a mean of 63.06%. 
The study also revealed that junior doctors performed better than consultants (p=0.008), but 
were more likely to feel uncomfortable administering PSA (0.031). A significant relationship 
between pharmacology knowledge and levels of comfort was also revealed, with those 
scoring higher in this section being more comfortable identifying and managing complications 
related to PSA (p=0.014).  
The equipment and drug audit identified many deficiencies in some of the locations assessed. 
These locations will require major improvements in order to increase patient safety. The audit 
also identified locations that are well equipped that only require minor improvements.  
PSA offers an alternative to general anaesthesia in a theatre environment; however, in order 
to ensure patient safety, practitioners need to adhere to recommended practice guidelines 
and the required equipment and drugs need to be readily available.  
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 Chapter One  Overview of the research 
1.1 Introduction 
The assessment of procedural sedation and analgesia (PSA) practices at Chris Hani 
Baragwanath Academic Hospital (CHBAH) was performed in order to understand who is 
responsible for its administration, the level of awareness of PSA guidelines and the level of 
comfort felt by those administering PSA. This chapter provides an overview of the area that 
was studied and includes the background to the study; the problem statement; the aims and 
objectives; relevant definitions and a brief overview of methodology that was followed. The 
significance of this study for CHBAH will also be discussed. 
1.2 Background 
PSA has been widely used since its origin in dental anaesthesia in the 1970’s. Since that time, 
the advancement in the pharmaceutical industry has led to the evolution and discovery of 
many new short-acting drugs and refined knowledge of pharmacokinetic principles. This has 
led to PSA becoming a widely accepted and practised alternative to general anaesthesia but 
has simultaneously required the formulation of specific guidelines for the safe practice of PSA. 
(1) 
PSA aims to achieve levels of sedation for diagnostic and therapeutic interventions in which 
the patient is able to maintain cardiorespiratory function. The techniques also aim to provide 
appropriate analgesia and amnesia for procedures that are otherwise disagreeable to patients 
(2). Currently PSA is employed in both medical and surgical settings, including radiology, 
gastroenterology, plastic surgery, dermatology, cardiology and the emergency department 
(ED) setting (3, 4). 
PSA offers an attractive alternative to general anaesthesia as it reduces hospital stay and 
operating room time. Thus resources, both financial and human may be more efficiently 
utilised (5). The demand for health services is ever-growing and it is not a uniquely South 
African phenomenon that the demand for hospital beds and operating room time is 
increasing (1). The cost of performing a procedure with PSA rather than under general 
anaesthesia is also much reduced (6, 7).  The option, therefore, to perform certain procedures 
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under PSA offers an appealing alternative (5). Furthermore trained non-anaesthesiologists are 
able to provide PSA thereby reducing the workload on a diminishing number of 
anaesthesiologists (6).  
The increasing use of PSA has also required professional bodies to provide guidelines to 
ensure consistent standards of care and patient safety. Sedation has traditionally formed part 
of the discipline of anaesthesia. International societies, such as the American Society for 
Anesthesiologists (ASA) and the European Society of Anaesthesiology (ESA) and national 
societies, such as the South African Society of Anaesthesiologists (SASA), have published 
guidelines for PSA (2, 3, 8, 9). Emergency medicine (EM) and gastroenterology are specialities 
that employ PSA commonly and therefore their governing bodies have also published 
speciality-specific guidelines (10-13). The guidelines provide direction with regard to 
personnel and their skills requirements, drugs and dosing, monitoring equipment, and detail 
patient selection and evaluation criteria. 
The multiple guideline sources serve to emphasise the importance of following policies and 
protocols in order to avoid adverse patient outcomes. The incidence of adverse events is 
difficult to assess due to inconsistent findings in research conducted across the disciplines 
that employ PSA (14). ASA liability claims for 2009 show that procedures performed outside 
the operating room had a higher incidence of death compared to operating room procedures, 
with 50% of remote location deaths involving PSA. Respiratory dysfunction was found to be 
the most common complication. (15) Complication rates in South Africa show a mortality rate 
of 1 per 7500–11 000 endoscopic procedures and 0.03% of all procedures using PSA (16). 
These figures may appear low but are of concern as they are higher than those for general 
anaesthesia for outpatient procedures (1). Anecdotally it is also known that adverse events 
are under-reported. 
1.3 Problem statement 
The doctors of CHBAH make use of PSA techniques in a number of departments; however, it 
has been observed that the regulations formulated by SASA to ensure the safe performance 
of PSA are unfamiliar to some health care professionals involved. Furthermore, there is no 
record that anyone has ascertained whether the recommended equipment and drugs 
required for the safe delivery of PSA are available. 
[12] 
 
 
The perceived consequences of these inadequacies are that PSA is being provided by 
personnel who may lack the necessary knowledge and skill to offer a safe procedure by being 
ill-equipped to deal with possible complications that may arise. In addition, procedural and 
emergency equipment and drugs may not be available. This places patients at an increased 
risk of adverse events. 
1.4 Purpose 
The purpose of this research was to describe the profile of non-anaesthesiologist PSA 
providers at CHBAH, their awareness of the SASA Sedation Guidelines 2010 and their level of 
comfort when performing PSA. The available equipment and drugs in PSA settings outside the 
operating theatre complexes was also assessed. 
1.5 Objectives 
The objectives of the study were to: 
 describe the professional level of respondents 
 describe respondent PSA and resuscitation training 
 describe the locations and procedures for which PSA is performed 
 assess the level of awareness of PSA guidelines (SASA) 
 describe the comfort level of practitioners when performing PSA 
 compare the level of PSA knowledge by professional level 
 compare the level of PSA knowledge by clinical department 
 compare the level of comfort by professional level 
 audit the availability of recommended drugs and equipment. 
1.6 Research definitions 
The following definitions will be used in the study.  
PSA:  procedural sedation and analgesia is the use of pharmacological and non-
pharmacological methods to reduce patients’ discomfort or pain and anxiety associated with 
a procedure. 
[13] 
 
ASA physical status classification: the American Society of Anesthesiologist’s risk assessment 
for patients undergoing anaesthesia. The classification is detailed in Table 1.1. 
Table 1.1  ASA physical status classification (17) 
 
Class Description 
I A normal healthy patient 
II A patient with mild systemic disease 
III A patient with severe systemic disease 
IV A patient with severe systemic disease that is a constant threat to life 
V A moribund patient who is not expected to survive without the operation 
 
Emergency medicine department/casualty: the department responsible for the initial 
assessment, triage and management of patients. Patients will either be treated and 
discharged or triaged to one of the following areas for further management. 
Internal medicine casualty: the area that is responsible for assessment and management of 
patients with medical complaints; 
Surgical casualty: the area that is responsible for assessment and management of patients 
with general surgical complaints; 
Orthopaedic casualty: the area that is responsible for assessment and management of 
patients with orthopaedic complaints;  
Trauma casualty: the area that is responsible for assessment and management of patients 
with trauma. 
Intern: a doctor who has graduated from university and is completing further supervised 
training for a period of two years. This category of doctors is not registered by the HPCSA for 
independent practice. 
Community service doctor: a doctor who is completing his/her community service as 
prescribed by the HPCSA prior to being granted full registration for independent practice. This 
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doctor has usually completed two years internship which is acknowledged as an extended 
period of training following graduation with a medical degree. 
Medical officer: a doctor employed by the provincial government in a designated medical 
officer post. This doctor may have no formal postgraduate training in the discipline in which 
he/she may practice.  
Registrar: is a doctor who is in the process of acquiring a specialist qualification endorsed by 
the HPCSA for specialist practice. 
Consultant: a doctor who has a specialist qualification for a specified field endorsed by the 
HPCSA. 
Anaesthesiologist: a doctor who has a specialist qualification endorsed by the HPCSA for 
specialist anaesthesiology practice. This status may be conferred on doctors who have 
obtained the Fellowship of the College of Anaesthesia or a MMed (Anaesthesia) from a 
university. 
Non-anaesthesiologist: a medical doctor or nurse who does not have specialist anaesthesia 
training but may be involved in administering anaesthesia and related services such as PSA. 
Observer: a medical professional (doctor or nurse) responsible for monitoring a patient during 
and after the administration of PSA. 
Operator: a medical doctor responsible for performing a procedure in which PSA is required. 
Sedation practitioner/sedationist: a medical professional responsible for administering 
sedation and/or analgesia drugs, and monitors the clinical effects of these drugs. 
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1.7 Demarcation of study field 
The study was conducted at CHBAH and involved the departments of general surgery, trauma, 
radiology, emergency medicine, orthopaedic surgery and internal medicine. The physical 
locations audited were: 
 radiology computed tomography (CT) scanner suite 
 medical casualty 
 endoscopy suites - upper and lower endoscopy suites 
 endoscopic retrograde cholangiopancreatography (ERCP) suite 
 emergency medicine department 
 surgery casualty 
 trauma casualty and resuscitation area 
 orthopaedics casualty procedure room. 
In the study these departments will be referred to as “the departments”. 
1.8 Ethical considerations 
Verbal assent was obtained from the heads of departments of general surgery, trauma, 
radiology, emergency medicine and orthopaedic surgery prior to the proposal being 
submitted to the Human Research Ethics Committee (Medical) of the University of the 
Witwatersrand.  
Ethics approval was obtained from the Human Research Ethics Committee (Medical) 
(Appendix 1) and permission was granted by the Post-Graduate Committee of the University 
of the Witwatersrand (Appendix 2), the CHBAH Medical Advisory Committee (Appendix 3) and 
from the Heads of Departments of general surgery, trauma, radiology, emergency medicine 
and orthopaedic surgery (Appendix 4).  
Upon assent from the listed departments, a self-administered questionnaire was distributed 
to potential participants. The questionnaire contained an information letter (Appendix 5) 
detailing the purpose of the study, ethics and CHBAH approval and the rights of participants 
to anonymity and withdrawal. The agreement to complete the questionnaire (Appendix 6) 
implied consent. Anonymity of participants and questionnaires was ensured by not recording 
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participants’ names on the questionnaires. Furthermore, confidentiality was ensured as the 
researcher and supervisors were the only people who had access to the raw data.  
The study was conducted in adherence to the principles of the Declaration of Helsinki (18). 
1.9 Research methodology 
1.9.1 Research design 
A cross-sectional prospective, descriptive, contextual study design was used.  
1.9.2 Study population 
Doctors working in the general surgery, trauma, radiology, emergency medicine, orthopaedic 
surgery and internal medicine belonging to the professional levels second year intern, 
community service officer, medical officer, registrar and consultant formed the population 
group studied. All interns in their second year of internship were selected as they would have 
had sufficient exposure to PSA during their clinical rotations in their first year. It is 
acknowledged that some of these interns will have rotated through anaesthesia, and would 
have had some formal exposure to sedation practice. First year interns were thus excluded as 
their exposure to PSA would be limited.  
1.9.3 Study sample 
Sample size 
All doctors in the departments were identified and eligible to participate. A sample was 
realised from the number of respondents. 
Sampling method 
All members within the departments were identified. A convenience sampling method was 
used for registrars as this group of doctors rotate amongst three academic hospitals affiliated 
to the University of the Witwatersrand. Registrars who were rotating through CHBAH at the 
time of the study were selected. 
[17] 
 
Inclusion and exclusion criteria 
Inclusion criteria 
 Medical doctors from the departments of general surgery, trauma, orthopaedic 
surgery, radiology, emergency medicine and internal medicine 
 Professional levels second year intern, community service officer, medical officer, 
registrar and consultant. 
Exclusion criteria 
 Medical doctors who indicated that they were never involved in the administration of 
PSA at CHBAH 
 Medical doctors who declined to participate. 
 First year interns 
1.9.4 Data collection  
Questionnaire development 
Data collection was done with the use of two tools: a self-administered questionnaire and an 
equipment and drugs audit checklist. The questionnaire was developed based on the 2010 
SASA Guidelines for the provision of PSA to adults and was validated by an expert panel of 
anaesthesiologists, with sub-speciality in pain, to ensure content and face validity. 
All medical doctors that fit the inclusion criteria were identified. The questionnaire was 
distributed to those who agreed to participate. Questionnaires were collected by the 
researcher and kept in a box to which only the researcher and supervisors had access. 
Equipment and drugs audit 
The PSA locations identified were audited according to the SASA Basic Equipment and Drugs 
for Procedural Sedation and Analgesia (PSA) (3) checklist (Appendix 7).  
All data obtained from both the questionnaire and the audit was captured onto an Excel 
spread sheet for analysis. Quality control checks were done to ensure data was captured 
accurately. 
 
[18] 
 
1.9.5 Data analysis 
Data was analysed using descriptive and inferential statistics with the assistance of a 
biostatistician. For descriptive analysis of data that are normally distributed, mean and 
standard deviation (SD) was used.  
1.10 Significance of study 
This study was the first to evaluate PSA practices at CHBAH and will provide a baseline 
understanding of PSA practices and the problems that surround its safe administration. 
Furthermore, it has laid a foundation for further studies to be conducted on this topic.  
More specifically the information gathered has shed light onto who is responsible for PSA, 
their level of training, their awareness of SASA Sedation Guidelines and their level of comfort 
when administering PSA. In addition, deficits of equipment and drugs in PSA locations were 
ascertained.  This information will assist in identifying areas for improvement, thus enabling 
directed measures to be taken to enhance patient safety when PSA is administered. The 
Department of Anaesthesiology is in the position to assist non-anaesthesiologists to make 
improvements by providing both knowledge and training to non-anaesthesiologists, and by 
directing suitable equipping of non-operating room settings with the required equipment and 
drugs.  
1.11 Validity  
Validity and reliability was ensured and will be detailed in chapter three.   
1.12 Project outline 
The study is presented as follows:  
In chapter one an overview of the study was provided. A review of the relevant literature is 
presented in chapter two. Chapter three describes the research methodology in detail. The 
results and a discussion thereof are presented in chapter four. In chapter five a summary, 
limitations, recommendations and conclusions from the study is discussed. 
 
[19] 
 
1.13 Summary  
In this chapter an overview of the study has been given. It has described the background; 
problem statement; aims and objectives; the research design and methodology; importance 
of the study and ethical considerations. In the next chapter a review of the literature related 
to the topic under research is presented.  
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 Chapter Two  Literature review 
2.1 The concept of safe practice 
An improvement in the standards of care in the conventional theatre setting has lead to a 
reduction in morbidity and mortality (19). This is due to the great emphasis being placed by 
anaesthesiology societies on patient safety and quality of care. The World Federation of 
Societies of Anaesthesiologists (WFSA) and the European Board of Medical Specialists have 
developed standards for safe anaesthesia practice in which mandatory requirements are 
detailed. These include pre, intra and post-anaesthesia assessment and monitoring guidelines. 
Standards for training, documentation and accreditation as well as professional and ethical 
conduct towards fellow health care providers and patients are discussed. (8, 20) While these 
standards are intended for anaesthesia professionals, and focus on requirements in an 
operating theatre, they also refer to the importance of training and assisting non-
anaesthesiologists to provide safe anaesthesia care (20). PSA is provided by non-
anaesthesiologists and hence these standards should be used to assist with its delivery. 
Despite best efforts, there is often a large gap that exists between what evidence-based best 
practice advocates and reality (21). In order to bridge this gap, one needs to understand the 
contributing factors to its formation, and put structures in place to assist all involved with 
health care delivery to practise best practice (22). The field of PSA is but one area where such 
a gap may exist. A greater understanding of the problems with its delivery must be sought to 
improve patient safety.  
2.2 PSA guideline development 
The birth and subsequent growth of PSA occurred in the field of dentistry in the middle of the 
20th century. Niels Jorgensen, Ed Driscoll and Norman Trieger were the first to combine 
general anaesthetic agents in sub-anaesthetic doses with local anaesthetic agents for dental 
procedures. This paved the road for Drs Harry Langa and Wayne Hiatt, who did pioneering 
work with nitrous oxide in oxygen for PSA. The American Dental Association’s Guidelines for 
Teaching the Comprehensive Control of Pain and Anxiety in Dentistry was drawn up in 1970, 
and served as the first guideline for PSA. (23)  
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The demand for PSA services has since grown rapidly, with an increase in procedures 
performed outside the operating theatre (24, 25). This trend, however, has been associated 
with a rise in morbidity and mortality when compared to procedures performed in the 
operating room (14, 26) thus necessitating the development of guidelines in order to 
standardise practice (1, 11) and to improve patient safety (2, 3). PSA has traditionally formed 
part of anaesthesia practice and therefore the SASA, ASA and ESA guidelines will be discussed 
in detail. The use of PSA has extended to multiple areas. As such  the American College of 
Emergency Physicians (ACEP), the Emergency Medicine Society of South Africa (EMSSA) and 
the American Gastroenterology Association (AGA) represent some organisations that have 
formulated their own guidelines to suit their specific needs (10-12).  
2.3 Understanding PSA 
PSA encompasses a range of altered levels of consciousness and is a group of techniques 
employed for selected diagnostic and therapeutic procedures (3). The identified levels of 
sedation range from mild sedation or anxiolysis and progress to moderate sedation, deep 
sedation and finally general anaesthesia (2, 3). Each level is characterised by a specific 
response and cardiorespiratory parameters, as detailed in Table 2.1.  
Table 2.1  Levels of sedation and physiological characteristics (2, 3) 
 
 Mild Sedation/ 
anxiolysis 
Moderate 
Sedation 
Deep 
Sedation 
General 
Anaesthesia 
Responsiveness Responds to 
verbal stimuli 
Purposeful 
response to 
verbal or tactile 
stimuli 
Purposeful 
response to 
repeated or 
painful stimuli 
Unable to rouse 
Airway Unaffected No intervention 
required 
Intervention 
may be 
required 
Intervention 
often required 
Spontaneous 
ventilation 
Unaffected Adequate May be 
adequate 
Frequently 
inadequate 
Cardiovascular 
function 
Unaffected Usually 
maintained 
Usually 
maintained 
May be 
impaired 
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SASA also draws a distinction between simple and advanced sedation. Simple sedation is 
defined as sedation using only one of the following regimens: 
 benzodiazepines via the oral, rectal or trans-mucosal route 
 nitrous oxide in no less than 50% oxygen, inhaled 
 intravenous (IV) midazolam, titrated to response but not exceeding 0.1mg/kg.  
Advanced sedation is defined as: 
 the use of a combination of drugs, via any route 
 use of the IV route for drug administration (except IV midazolam) 
 inhalational agents, except nitrous oxide in no less than 50% oxygen 
 infusion techniques.(3) 
The distinction is important due to the consequences for monitoring and fasting 
requirements. These will be discussed in their relevant sections.  
2.4 Monitored anaesthesia care 
The literature also refers to monitored anaesthesia care (MAC) in the context of sedation 
practice. It is often used interchangeably with moderate sedation but the distinction is 
important. The ASA defines MAC as the provision of sedation together with the ability to 
convert to general anaesthesia, and the ability to perform rescue measures should the level of 
sedation progress to deeper than anticipated levels. Thus it does not form part of the 
sedation continuum, but rather refers to PSA in which an anaesthesiologist is required. 
Moderate sedation, on the other hand, should never progress to the point of airway 
compromise and the need for general anaesthesia requirements. Additionally, a practitioner 
of MAC must be able to provide post-sedation care that extends beyond the requirements of 
moderate sedation. This includes ensuring a return to a normal level of consciousness, 
adequate levels of analgesia, and ensuring no adverse drug-related side-effects, for example 
postoperative nausea and vomiting. (27) 
Interestingly, no reference is made to MAC in the ASA Practice Guidelines for Sedation and 
Analgesia by Non-Anesthesiologists (2), nor by SASA in the SASA Sedation Guidelines 2010 (3). 
This may be due to the fact that non-anaesthesiologists should not perform sedation at the 
MAC level as they do not possess the necessary knowledge or skill to do so (1).    
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A further distinction between MAC and sedation is made in the Basic Standards for 
Monitoring. Both the ASA and the WFSA reflect this (8, 28). MAC standards for basic 
anaesthetic monitoring are considered together with those for general and regional 
anaesthesia, thereby emphasizing that MAC is an anaesthesiology-driven service (28). In 
contrast the PSA guidelines are intended for use by non-anaesthesiologists, and so a different 
set of standards has been drafted (2). The standards for monitoring for PSA performed by 
non-anaesthesiologists will be discussed in due course. 
Despite the definitions provided some authors group moderate sedation and MAC together. 
For clarity this will be stated when reference is made to these articles. 
2.5 Aims of PSA 
The aims of PSA are worth consideration as these may assist with appropriate patient and 
procedure selection. SASA Guidelines state that PSA should aim to reduce patients’ 
discomfort or pain and anxiety associated with a procedure, ensuring patients’ safety and 
returning them to a state where they are eligible for discharge (3). Moreover, EMSSA states 
that PSA, while fulfilling these objectives, should minimise fluctuations in cardiorespiratory 
function and should not compromise the patient’s airway reflexes (11).  
2.6 Adverse events associated with PSA 
The growth in PSA has required investigation into the adverse events that occur during its use. 
This serves to assist medical professionals to be aware of pitfalls and take steps to improve 
patient safety. A number of studies examine the incidence and nature of adverse events that 
occur during PSA. These complications occur for a variety of reasons namely patient, 
sedationist, location and procedural factors. A pre-procedure assessment will alert the 
sedationist to potential problems and will determine ASA physiological status classification. 
(29)  A classification of III or more is associated with a higher incidence of adverse events 
during PSA (30), thereby explaining the reason for the ASA and SASA recommendation to non-
anaesthesiologists to avoid performing PSA in patients with this classification (2, 3). Other 
patient related risk factors are extremes of age, obesity, obstructive sleep apnoea and a 
known difficult airway. Sedationist factors relate to the level of knowledge and skills required 
for safe PSA practice. It is these factors that are discussed extensively in PSA guidelines (2, 3, 
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9-11, 13). Procedure related risk factors are those procedures in the facial or oral area, prone 
position and lengthy or complex procedures (26).  Lastly, office-based PSA is associated with a 
higher complication rate (24), a reason potentially being the lack of support resources 
available in a hospital when complications do occur.  
It must be noted that complication rates differ for a number of reasons, namely heterogeneity 
of study designs, drug protocols, procedures, definitions of adverse events, patient 
demographics and comorbidities, to name a few. The data presented does, however, provide 
some insight to common problems that arise during PSA.  
Many of the studies examining adverse events are discipline specific; however, Pino (31) 
undertook to establish the overall complication rates associated with PSA at the 
Massachusetts General Hospital. Complications that occurred most frequently were 
respiratory in nature, with oxygen desaturation and apnoea in 0.12% of cases. Cardiovascular 
complications, most often hypotension, and nausea and vomiting occurred in 0.1% and 0.11% 
of cases respectively. 
PSA is frequently used in the ED for a variety of surgical, medical and orthopaedic procedures. 
A number of studies have been done to establish complication rates such as A Canadian 
Community Effectiveness and Safety Study (ACCESS) (32) carried out in a Canadian community 
ED staffed by family physicians, specifically trained in PSA. The overall adverse incident rate 
was 18% with the most common event being apnoea in 10% of cases, followed by inadequate 
sedation (2.5%) and bradycardia (1.9%). There were no reports of serious adverse events such 
as cardiac arrest or respiratory depression requiring intubation. (32) 
In contrast to the ACCESS study Campbell et al. (33) examined adverse events in a tertiary ED. 
Overall adverse events occurred in 1.7% of cases, with a 1% incidence of oxygen desaturation 
and 0.8% incidence of hypotension. Another recorded adverse event was a case of emergence 
agitation when ketamine was used. A further study that reviewed PSA practices from 14 ED’s 
showed an overall complication rate of 4.1%. This rate, however, did not vary with the 
presence of a dedicated sedationist. (33) Each of these studies took place in very different 
settings, with a variation in complication rates. This may be explained by the presence of 
added resources to train ED staff on PSA, and more stringent protocol adherence in a tertiary 
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environment. Despite the higher complication rate in the community ED setting, sedationists 
were able to identify and manage these problems with no serious consequences. (32) 
Gastrointestinal tract (GIT) endoscopy is prolific in its research on PSA due to the growth in its 
use for endoscopic procedures. In 1995 Quine et al. (34) examined the incidence of both 
cardiac and pulmonary adverse events for upper GIT endoscopy and  showed the incidence to 
be 0.5%. At that time PSA guidelines for endoscopy had not been developed, yet it was 
recognised that a lack of basic standards for monitoring and care may have contributed to the 
morbidity seen. (34) More recent studies chose to only look at respiratory adverse events. Rex 
et al. (35), in a study on trained nurse-administered sedation using propofol for endoscopic 
procedures, showed  the incidence of respiratory adverse events to range between 1 per 500 
cases to 1 per 1000 cases . A similar study showed respiratory adverse events, including 
apnoea, laryngospasm and aspiration, to occur in 0.7% of cases (36). While these studies 
provide a degree of insight to the nature and frequency of respiratory complications, they do 
not define the time period for apnoea nor do they comment on oxygen saturation, thereby  
underestimating these complications (31). Indeed, it is estimated that cardiopulmonary 
events account for 50% and 60% of endoscopy-related morbidity and mortality respectively 
(37). 
ERCP is worth specific mention as it is a procedure commonly performed using PSA, with a 
large proportion of patients having an ASA classification of III or more. It is associated with the 
highest incidence of adverse events and has the highest incidence of sedation-related 
mortality, compared to general anaesthesia. (38)  
While there is a great deal of international data available, there are few South African studies 
examining the incidence of PSA adverse events. Despite this it has been stated that while the 
complication rates are low, they are higher than those for general anaesthesia (1). 
Furthermore it is known that mortality occurs more frequently outside the operating theatre, 
with an estimated rate of one per 7500 – 11 000 endoscopic procedures and 0.03% of all 
procedures using PSA (16). Despite the paucity of South African data, anecdotally it is known 
that complications are under-reported, and so the incidence may indeed by higher. In keeping 
with the international literature however, cardiopulmonary complications occur with the 
greatest frequency (1).  
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The data discussed aims to shed light on adverse events associated with non-
anaesthesiologist PSA but few studies compare anaesthesiologist to non-anaesthesiologist 
PSA adverse events (14). It is assumed that anaesthesiologists are better equipped to provide 
care given their training but only one study was found questioning this assumption. The study 
did show a reduced rate of cardiopulmonary complications when PSA is performed by an 
anaesthesiologist (30).  
2.7 PSA Guidelines: Recommendations for Safe Practice 
2.7.1 Personnel requirements for PSA 
SASA Guidelines state that in order to provide safe PSA, a sedation team is required. The 
sedation practitioner is responsible for the pre-procedure assessment, administration of PSA 
and monitoring the patient until fully recovered and the operator is responsible for 
performing the procedure. The sedationist and operator may perform both duties for simple 
sedation techniques; however, a dedicated sedationist is required if advanced techniques are 
used. The observer is a second person responsible for monitoring the patient and should be 
able to assist with the management of complications. Recovery room personnel are also 
required. (3)  
ASA Guidelines are not as clear on this topic. They echo the acceptability of the sedationist 
and operator performing a dual function and state that a dedicated observer is only required 
for deep sedation. For moderate sedation, the observer may be involved with other minor 
tasks once the patients’ vital signs have stabilised. (2)  
Other: ESA Guidelines state that the sedationist and operator roles are performed by one 
practitioner, and that a dedicated observer must be present to monitor the patient during the 
procedure (9).  EM Guidelines vary in personnel requirements. The ACEP states that an 
observer, who is able to monitor the patient, is only required for moderate and deep 
sedation, and that once again, the sedationist and operator may perform both tasks (10). AGA 
echoes the ASA Guidelines (13). In contrast the EMSSA states that only one person is needed 
to administer, monitor and manage potential PSA complications. The second member of the 
team is the operator, whose role is limited to the performance of the procedure (11).  
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2.7.2 Training requirements 
SASA Guidelines state a sedationist must have a registered medical degree, and be able to 
demonstrate current knowledge and skill in PSA and its complications. This includes 
pharmacokinetic and pharmacodynamic knowledge on drugs used for PSA, different sedation 
techniques, and the ability to recognise and manage complications. Basic Life Support (BLS) 
and Advanced Cardiac Life Support (ACLS) are required. The observer must have the 
equivalent to nursing training, be able to monitor the patient, and recognise and assist with 
the management of airway compromise. BLS training is required. (3) 
ASA stipulates the need for training on drugs used, and the recognition and management of 
PSA complications. For moderate and deep sedation a BLS certified person should be present 
whereas an ACLS certified person should be available (one to five minutes away) for moderate 
sedation, and in the room for deep sedation. (2) 
Other: ESA recommends that the sedationist/operator have specialised PSA knowledge that 
encompasses theory of PSA practice, pharmacology of drugs used, knowledge of and skills to 
manage complications, such as airway management and advanced life support. The observer 
must be trained to monitor patient and should have BLS skills. (9) ACEP does not discuss 
training requirements and EMSSA only recognises the importance of pharmacology 
knowledge and the ability to diagnose and treat complications (11). In contrast, AGA details 
specific requirements for both sedationists and observers. Competence in the relevant 
pharmacology, recognition and management of complications, ALS principles and airway 
management is required. The guidelines also discuss methods for training and accreditation. 
(13) 
2.7.3 Patient selection for PSA by non-anaesthesiologists 
SASA recommends that only ASA class I and II patients be eligible for PSA outside theatre as 
higher classes require greater levels of care (3).   
ASA recommends that for patients with significant underlying medical conditions, an 
anaesthesiologist should be consulted prior to PSA but does not provide a definition of what 
this may mean, and hence is at the discretion of the sedationist (2).  
[28] 
 
Other: ESA states that class I, II and stable class III patients are eligible for non-
anaesthesiologist PSA (9). The EMSSA states that ASA III and IV patients are not suitable for 
PSA (11). AGA also supports non-anaesthesiologist PSA for class I, II and III patients, but 
recommends anaesthesiologist PSA for ERCP, endoscopic ultrasound and patients with a prior 
PSA adverse event (13).  
All guidelines advocate a directed patient assessment with focus on medical conditions, prior 
general anaesthesia or PSA adverse events, allergies and current medications. Physical 
examination should include vital signs, cardiopulmonary examination and airway assessment 
(2, 3, 9-11, 13). In addition it is important to establish the time of last oral intake. While 
fasting is recommended for simple sedation, it is not an absolute requirement. SASA and ASA, 
however, prescribe the same fasting guidelines as for elective surgery, for advanced sedation 
(2, 3).  
The fasting guidelines developed by the EM societies are not as stringent, and state that the 
practitioner should consider the level and timing of sedation relative to the last oral intake 
(10, 11). Due to the busy nature of the ED, the fact that ASA fasting guidelines apply 
specifically to elective surgery and the lack of evidence supporting ASA fasting guidelines, EM 
does not support these fasting protocols (10, 11, 39). Aspiration pneumonitis is acknowledged 
as a serious complication however it is an exceedingly rare complication during PSA, hence 
the recommendation to take the circumstances mentioned into consideration (10, 39).  
2.7.4 The Issue of informed consent 
SASA dictates that written and verbal informed consent be obtained prior to the 
commencement of PSA, and should include information about the procedure and PSA 
technique, possible complications and alternatives (3).  
ASA makes no specific mention of informed consent.  
Other: ESA only states that patients must be able to give informed consent (9). ACEP argues 
that an additional consent form to that required when registering at an ED is unnecessary as it 
does not affect clinical outcome or patient satisfaction. They go on to say that patients 
requiring PSA are often either in a great deal of pain, anxious or of an altered state of 
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consciousness and in such cases, implied consent is sufficient. (10) This is another area in 
which the EM approach differs from other disciplines. 
2.7.5 Monitoring requirements 
In a review of the ASA closed claims database for claims outside the operating theatre 
(including MAC) researchers showed that more than 50% of respiratory complications could 
have been prevented with better monitoring (26). The value of monitoring is therefore 
demonstrated by its ability to reduce the incidence of adverse events by alerting PSA 
providers to physiological abnormalities (19).  
SASA: monitoring requirements will vary according to the level of sedation planned and the 
physiological profile of the patient; nevertheless SASA recommends basic clinical monitoring 
for all PSA. Monitoring of level of consciousness, pain and anxiety is done by maintaining 
verbal contact with the patient or by tactile stimulation. Other mandatory clinical monitoring 
includes ventilation, via observation or auscultation, and oxygenation, heart rate and rhythm 
with the aid of pulse oximetry. For deeper levels of sedation, blood pressure monitoring at 
five minute intervals should be added. Furthermore, electrocardiogram (ECG) monitoring is 
advised for patients with cardiovascular disease. (3) 
ASA Guidelines are similar to those of SASA but add that if the procedure precludes verbal 
contact for monitoring level of consciousness, a non-verbal signal should be discussed with 
the patient prior to commencement of PSA (2). 
Other: ESA recommends the use of pulse oximetry, blood pressure measurement, ECG 
recording and visual observation of respiration (9). ACEP guidelines recommend the use of 
pulse oximetry only in patients with a high risk of hypoxaemia and state that in otherwise 
healthy patients in which verbal communication is possible, pulse oximetry may not be 
needed (10). AGA guidelines advocate the assessment of level of consciousness commencing 
prior to PSA but do not specify the tool to be used. In addition these guidelines state that the 
use of blood pressure and pulse oximetry devices is supplementary to observation of the 
patient. While it is acknowledged that these monitoring devices play an important role for IV 
PSA techniques, it implies that observation is the primary tool for patient monitoring. (13) 
This may be problematic as many studies have shown that observers do not detect 
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physiological abnormalities as quickly as monitoring devices (40, 41). EMSSA guidelines 
require the monitoring of level of consciousness, airway patency, respiration and oxygen 
saturation, ECG and blood pressure (11). 
There is much debate about the value of pulse oximetry as studies have shown that its use 
does not reduce mortality (19). A Cochrane Review examining the effect of pulse oximetry on 
perioperative adverse events showed that while pulse oximetry did reduce the incidence of 
hypoxaemia, it did not reduce the incidence of postoperative cognitive dysfunction and 
respiratory, cardiovascular or neurologic complications (42). Conversely, others argue that it 
plays an important role in reducing the rate of adverse events (26). It thus becomes important 
to understand the information that pulse oximetry provides. The ASA highlights that it is not 
an indicator of ventilation, but rather an indicator of oxygenation and as such assists with the 
detection of hypoxaemia (2). Therefore significant alveolar hypoventilation and hypercarbia 
can still occur in the presence of normal oxygen saturation (40). If these limitations are 
understood then its value for detecting hypoxaemia, and potentially avoiding serious adverse 
events that may occur as a result (2), can be appreciated.  
Supplemental oxygen may further obscure the detection of respiratory depression when 
pulse oximetry is used as a surrogate marker for ventilation (19, 43). This is because an 
increased oxygen reserve created with supplemental oxygen increases the time to 
desaturation, masking respiratory depression or apnoea (10, 40). Notwithstanding, 
supplemental oxygen will reduce hypoxaemia which is particularly desirable in certain 
patients, such as those with ischaemic heart disease (44). 
A true indicator of ventilation and the current gold standard is capnography (3). It alerts the 
sedationist to hypoventilation and apnoea more rapidly than observation or oximetry (40, 41). 
Furthermore, its ability to detect respiratory compromise is not altered by supplemental 
oxygen – the amplitude of the graph is reduced but apnoea detection remains unaffected 
(41). It is not, however, a mandatory requirement for minimal and moderate sedation for any 
of the anaesthesia or EM societies but is advised for patients at risk of airway compromise (3), 
deep sedation or when direct visualisation of respiration is not possible, for example during 
magnetic resonance imaging (2).  
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Level of consciousness is an important component to monitor during PSA, with observation, 
verbal and tactile stimulation being the primary means of assessment. Bispectral Index 
Monitoring (BIS) is a recorded measurement that makes use of electroencephalographic 
parameters obtained by monitoring frontal cortex activity (10, 44). The BIS scale ranges from 
zero, which corresponds to no cortical activity or coma, to 100 or fully awake (44). It has been 
used to guide sedation in the ICU setting (45) and has been shown to reduce awareness under 
general anaesthesia (19) and so researchers have investigated its use in the setting of PSA. 
Chen et al. (45) showed that BIS was not useful during the initial and recovery phases of PSA 
using propofol due to a lag between clinical sedation assessment and the BIS. While 
sedationists felt that BIS was more useful during the maintenance phase of PSA, there was a 
wide range in the BIS score (45).  Another study showed that BIS is more useful to distinguish 
deep sedation from general anaesthesia but is unable to differentiate along the deep to mild 
sedation spectrum (46) or to differentiate comfortable from agitated patients, and patients in 
pain (47). In contrast to these findings, Bower et al. (48) found that BIS was an accurate 
measure of sedation and that it could be used to titrate additional sedation requirements. 
Large variation in the BIS score was found at deeper levels of sedation and no link between 
BIS score and physiologic measures, such as blood pressure, heart rate and pulse oximetry, 
was found (48).   
It can be seen that great variability in the BIS literature exists. Both SASA and the ASA do not 
make reference to BIS in their guidelines and the ACEP acknowledges the technology and its 
potential but concludes that the data is insufficient to recommend its routine use (10). Until 
more consistent data is available, clinical evaluation of level of consciousness will remain 
standard practice.  
2.7.6 Documentation 
SASA stipulates the need for documentation of all components surrounding PSA. 
Documentation prior to PSA should detail consent, information and instructions given to the 
patient about PSA and a medical history questionnaire. A pre-procedural checklist should also 
be completed, which includes information about prior sedation history, fasting, chronic 
medication, and physical examination. During the procedure a real-time record of events, 
drugs and vital signs must be recorded. This should extend into the recovery phase of the 
procedure, and patients should not be discharged until specific criteria are met. A Modified 
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Aldrete score of ≥ 9 is acceptable. Furthermore, the patient must be accompanied home by a 
responsible adult who is able to care for the patient and to contact medical services should 
any problems arise. (3)  
ASA advocates documentation of vital signs pre, intra and post-procedure for moderate and 
deep sedation. This should continue until the patient is recovered and eligible for discharge. 
Principles for recovery and discharge guidelines are listed. (2)  
Other: ESA documentation requirements are few. Frequent recording of vital signs and the 
level of consciousness is all that Is discussed (9). ACEP does not discuss documentation 
requirements whereas the EMSSA guidelines are in keeping with the SASA intra-procedural 
requirements (11). AGA requires documentation of the pre-procedure assessment, informed 
consent, intra and post-procedural vital signs, administered drugs, level of consciousness, pain 
and adverse events (13). 
2.7.7 Drugs and PSA techniques 
There are numerous techniques that can be employed to deliver safe and effective PSA. 
Regardless of technique one should consider the safety guidelines put forward by the various 
professional societies.  
SASA principles advocate the use of the smallest amount of drug necessary for the desired 
level of sedation and analgesia and individualised dose-titration to response. In order to do 
this effectively, the sedationist must have knowledge of the time to onset of action for the 
drugs being used (3). Furthermore, SASA cautions sedationists to avoid using the sedating 
properties of opioids for painless procedures (16). ASA and ACEP discuss drugs according to 
category and make recommendations accordingly, however, the same principles of titration 
and minimal dosing, particularly with reference to sedatives and opioids, apply (2, 10).  
It is at the discretion of the sedationist to choose a drug regimen. This choice should be 
governed by patient and procedural factors and his/her pharmacology knowledge and 
training (3).  
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Sedatives and opioids: these groups of drugs are used most commonly for PSA. They do have 
synergistic action and thus increase the risk of respiratory depression (2, 49). It is for this 
reason that the guidelines caution sedationists to administer each drug individually in order to 
better assess drug effect and to titrate as necessary (2, 3, 10, 11). Short-acting 
benzodiazepines used include midazolam and triazolam and opioids, which are also short-
acting, include fentanyl, alfentanyl, sufentanyl and remifentanyl (3). 
Ketamine is a dissociative agent that has sedative, hypnotic and analgesic properties (50). It 
may be used alone or in combination with other drugs, such as propofol or fentanyl. In 
contrast to benzodiazepines and opioids it has the advantage of preserving respiratory 
function. Its sialogogue effects, however, may negate this benefit (3). Another potential 
disadvantage is difficulty monitoring level of sedation due to the trance-like state that it 
produces (2).  
As stated previously ketamine may be used in combination with benzodiazepines, and was 
shown to be safer than a benzodiazepine-opioid combination for paediatric PSA in the ED 
setting (51). In addition, Chudnovsky et al. (52) reported a 6% incidence in respiratory 
compromise and a 7.14% incidence of emergence reaction in adults with a ketamine-
midazolam combination.  These complications were transient, with respiratory depression 
attributable to midazolam, and had no further sequelae (52). Ketamine may also be used with 
propofol in a preparation called Ketofol, the rationale being that lower doses of propofol are 
required thereby avoiding its depressant effects on the respiratory and cardiovascular 
systems. The lower dose of ketamine still provides analgesia but reduces drug-induced 
delirium. (53) Despite these theoretical advantages an ED study found adverse events rates 
comparable to but not better than propofol or etomidate alone and there was no 
improvement in recovery times (54).  
The use of propofol for PSA by non-anaesthesiologists is another debated subject. It offers a 
rapid onset to the desired level of sedation and then allows for maintenance of sedation by 
repeat boluses or a constant infusion titrated to effect. It also has the advantage of a rapid 
offset of action and has anti-emetic properties, all desirable features for PSA. (50)  
SASA recommends that propofol and other induction agents be used only by 
anaesthesiologists, critical care specialists or those with extensive sedation and anaesthesia 
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experience (3). ASA is not as prescriptive but does state that sedationists using propofol 
should be able to manage complications that may arise as a result of its use, including 
rescuing the patient from general anaesthesia (2). This implies that the use of propofol falls 
into the realm of MAC and consequently should be used by anaesthesiologists or those with 
anaesthesia training (27). Non-anaesthesiologists argue that numerous studies show that 
propofol, whether alone or in combination with benzodiazepines or opioids, is safe in the 
hands of trained non-anaesthesiologists (10, 13).  
The literature demonstrates the safety of trained non-anaesthesiologist administered 
propofol. Rex et al. (55) provides a synopsis of studies examining propofol use in the field of 
endoscopy. The cumulative data shows no deaths and one endotracheal intubation for a total 
of 220 000 procedures. The administration of propofol by appropriately trained nurses has 
also shown this practice to be safe (35, 36).  
In order to address this issue the AGA has developed its own set of sedation guidelines with 
the aim of setting standards for propofol use amongst endoscopists. It states that propofol 
can be used alone or in combination with other drugs, by trained personnel provided that 
dosing protocols are followed and that patients are continuously monitored throughout the 
procedure until fully recovered. (13) 
The field of EM has also investigated the use and safety of propofol in the ED. Studies have 
shown that general physicians and EM residents, who have received training on the use of 
propofol, are able to safely administer the drug for PSA in the ED (32, 56).  
Notwithstanding  cautious use of drugs, overdose does occur and so reversal agents, naloxone 
and flumazenil, must be readily available to treat patients with overdose of opioids and 
benzodiazepines respectively (2, 3, 10, 11, 13). Because the duration of action of opioids and 
benzodiazepines may exceed that of their reversal agents it is necessary to monitor patients 
with overdose for an extended period of time, and repeat reversal administration if overdose 
symptoms recur (3).   
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2.7.8 Equipment and emergency drugs 
SASA provides a detailed checklist of equipment for PSA and for any emergency that may 
arise during the procedure (Appendix 7). This includes equipment for oxygen delivery, airway 
management, monitoring, establishing IV access, drug infusions and other equipment 
required for resuscitation. In addition emergency drugs that must be immediately available 
are listed. (3)  
ASA has also included a checklist in its guidelines, but this list is focused on emergency 
equipment and drugs. Its requirements echo those of SASA except for cardiac defibrillators. 
ASA only deems it necessary to have a defibrillator immediately available for moderate 
sedation of patients with mild to severe cardiovascular disease, but should always be 
available for deep sedation. (2)  
Furthermore, ASA has also published guidelines on the provision of anaesthesia outside the 
operating room. While these guidelines are intended for anaesthesia personnel, the principles 
should be borne in mind by all medical professionals involved in anaesthesia-related services 
outside the operating room. A reliable source of oxygen, as well as a supplemental source of 
oxygen sufficient for the duration of the procedure, must be available and be checked prior to 
commencing any procedure. Suction and all equipment and drugs for both the intended 
anaesthesia and possible emergencies must be available. Emergency equipment must be 
checked to be working. Other requirements deal with the availability of sufficient space, 
electrical outlets and trained personnel to assist during and after the procedure. (57)  
Other: ESA does not discuss equipment requirements in detail and merely states that 
emergency and oxygen delivering equipment should be present and operational, and that 
personnel involved with PSA should be proficient with its use. Flumazenil and naloxone are 
stated as requirements (9). The ACEP recommends that equipment such as oxygen, suction, 
and equipment and drugs for advanced life support be available (10). No details about specific 
requirements are discussed. The AGA and EMSSA are more comprehensive in their guidelines, 
and follow the requirements set down by ASA (13). 
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2.8 Audit of equipment 
The guidelines discussed include a list of equipment and drugs that should be available for 
safe PSA. Most focus on emergency equipment; however, SASA provides a comprehensive list 
of drugs and equipment for PSA as well as emergency situations. Despite the importance of 
these requirements, particularly emergency equipment and drugs, few studies have 
performed an audit of equipment availability at sites where PSA is performed. In a Dutch 
national survey, Leroy et al. (58) included availability of emergency equipment as part of a 
study on guideline adherence. Results showed that only 41.1% of respondents indicated full 
adherence in this area. This may not be truly indicative of reality as figures were based on 
respondent perception. It does, however, reveal a problem with provision of emergency 
equipment. 
Pitetti et al. (59) allude to such an audit in their study on the effect on PSA practice after 
implementation of the Joint Commission on Accreditation of Healthcare Organization’s 
Guidelines but do not provide any results for this audit.  
2.9 Guideline adherence 
2.9.1 The role of guidelines in healthcare delivery 
The formulation of guidelines is directed by a need to improve healthcare safety, standards of 
care and treatment and costs (60-63). It is a tool that is used by many medical and surgical 
specialities, with PSA being no exception. A unifying purpose to the multiple PSA guidelines is 
standardised and safe care, while simultaneously addressing speciality-specific circumstances. 
(2, 3, 10, 11, 13) 
History has demonstrated the positive impact of such an intervention. Quine et al. (34) found 
in his 1995 study that high doses of midazolam, which may be indicative of limited 
pharmacology knowledge, and poor monitoring contributed to the high incidence of adverse 
events seen in endoscopic procedures. Similarly a 1994 study by Aslam et al. (64) identified a 
need for guidelines after demonstrating deficits in monitoring, drug knowledge and patient 
selection in the ED’s of England and Wales. The subsequent development and dissemination 
of guidelines have assisted to improve the PSA track record (44, 55, 59, 65), thereby 
illustrating their benefit. 
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2.9.2 Factors affecting guideline implementation  
Despite the good intentions of various societies responsible for developing practice 
guidelines, studies across a wide range of clinical fields have shown that awareness, 
knowledge, attitudes and adherence to guidelines is poor. These variables are often studied 
individually (66), but form part of a composite whole that influence guideline adherence. They 
are not unique problems to the field of PSA, and hence studies from other fields will be 
discussed as they provide valuable insight.  
Pathman et al. (60) suggest a model of awareness – agreement – adoption – adherence to 
explain the process to guideline adherence and was tested using vaccination guidelines. 
Findings supported the concept that the path to guideline adherence occurs in a sequential 
manner and that problems at any stage will negatively impact adherence (60). It is thus 
important to appreciate the complexity of adherence and the factors that impact guideline 
implementation. 
Pathman et al. (60) model provides one framework for understanding a complex process. 
Other factors, such as knowledge and attitude also play a role. These, together with 
awareness and adherence are discussed.  
Awareness 
Awareness is understood to mean knowledge of a guideline’s existence (66), and is suggested 
to be the first step to guideline adherence. The study by Hagemeister et al. (63) focused on 
the management of arterial hypertension, and showed adequate guideline awareness, 
defined more broadly as knowledge and acceptance of guidelines, to be present in only 18.8% 
of general practitioners (GP), 25.6% of physicians (internists) and 37% of cardiologists. 
Amongst general practitioners and physicians, those with ≥ 20 years in private practice 
showed the lowest levels of awareness. Proposed explanations for these findings were a 
reduced level of interest in continuing medical education and poor transfer of information to 
those in the private sector (63).  
Awareness and use of American Thoracic Society (ATS) and local guidelines for community 
acquired pneumonia was also studied. Once again, a low level of awareness of ATS guidelines 
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was found: 21% were not at all familiar with the guidelines, 29% had seen them, 30% had 
read them and only 20% used them. As with the hypertension study specialists, in this case 
pulmonologists and infectious disease specialists, were more likely to use the guidelines. This 
finding may highlight the influence of speciality affiliation and explain the reason for 
discipline-specific guideline development. This study also substantiates the concept that 
awareness does not necessarily translate into adherence. (62)   
Knowledge 
Knowledge is defined as the theoretical or practical understanding of a subject (67). A 
Canadian study focused on assessing PSA knowledge amongst radiology residents, with 
particular focus on pharmacology. The American College of Radiologists has published 
guidelines for radiologist-directed PSA, yet results showed that just over 50% of respondents 
knew the correct drug doses frequently used for PSA. Knowledge of onset of action and 
appropriate local anaesthetic doses was also poor. The study also emphasized that most 
respondents had not received PSA specific training, yet expressed the wish to have training 
incorporated into their curriculum. (68) 
In a study at Johns Hopkins Hospital knowledge of adult and paediatric PSA guidelines 
amongst EM practitioners was assessed and compared to practitioners in other specialities. 
Findings demonstrated greater adult PSA knowledge amongst EM practitioners, and pointed 
out knowledge gaps in specific areas. Specific areas of weakness were drug routes of 
administration, ketamine dose, ECG evaluation, post-sedation discharge criteria and PSA 
nurse administration guidelines. Interestingly, the study also demonstrated that these 
deficiencies could be remedied with a PSA course, with post-course test scores showing 
significant improvement. (69) This lends some support to the proposal of including PSA 
training in speciality curricula. 
Attitude 
Attitude is defined as settled way of thinking or feeling about something (67) and is another 
factor that influences adherence. Breakey et al. (70) illustrated that the use of PSA amongst 
paediatric and EM residents for lumbar punctures in paediatric patients was influenced by 
their perception of the degree of pain felt, which varied with age, and their perception of the 
[39] 
 
degree of pain associated with the procedure. Other factors were adverse events experienced 
with a particular technique and whether respondents had received formal PSA training. The 
source of training was important as instruction received from a superior or colleague was 
subject to bias and personal experience rather than practice guidelines, thereby enabling 
propagation of misinformation and bad habits. Once again, of those residents who had no 
training in PSA, an overwhelming majority (85%) felt that a formal program would be useful. 
The authors concur that such a program would address the problems of “underuse and 
misuse” of PSA. (70) 
Tunis et al. (71) further illustrate the impact of attitude on adherence. Their study revealed 
that specialists are more likely to have confidence in guidelines developed by their speciality 
societies (71), which is consistent with findings on guideline knowledge (62, 63). While most 
respondents agreed that guidelines have a positive impact on patient care, between 20% and 
25% were of the opinion that guidelines are too rigid, limit practitioner autonomy, and seek to 
create a one-size-fits-all model for patient care (71). This was particularly evident amongst 
private practitioners.  
Adherence  
Guideline adherence is understood to mean the use of guidelines for appropriate situations 
most of the time. Fanning (72) conducted a study at a Dublin-based teaching hospital 
exploring adherence to recommended PSA guidelines across both medical and surgical 
disciplines, and across the different training grades. The questionnaire assessed the types and 
locations of procedures performed, protocol usage, the use of standards for pre-procedural 
assessment, monitoring, post-procedure care and resuscitation skills, and pharmacology 
knowledge. While adherence for each of these elements varied, the overall adherence was 
poor. (72) The Royal College of Anaesthesia (RCA) reports on safe sedation practice suggests 
that lack of PSA knowledge and training, and the failure of disciplines to recognise the need to 
incorporate PSA into their respective curricula may be a reason for the discouraging findings 
on guideline adherence. The report goes on to make specific recommendations to address the 
situation, such as the provision of resources to train and assess sedationists and the 
appointment of consultants from anaesthesia and other relevant specialities to oversee PSA 
practice. (61) 
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A Dutch study on PSA guideline adherence amongst general paediatricians found equally 
disappointing results with full adherence being less than 25% for history taking, risk 
assessment, blood pressure monitoring, monitoring during recovery and rescue competence 
during recovery. Despite full adherence being low, the study defined non-adherence as a 
“gradual deviation from full adherence” rather than “absence of full adherence”. Even with 
this modified definition, low levels of adherence, such that patient safety would be 
compromised, were found in 25% of respondents. Reasons cited for these findings once again 
are related to PSA not being a formalised subject and scarce training opportunities. (58)   
Understanding adherence 
These studies serve to illustrate that a large gap exists between guideline development and 
practitioner awareness, knowledge and adherence. As has been indicated the reasons for this 
gap focus mainly on the low status of PSA in speciality curricula and the consequent limited or 
non-existent training for non-anaesthesiology specialists on the subject (58, 68-70, 72). Thus 
formalised training offers one solution to the problem. 
Tools, such as PSA forms, have also been shown to improve adherence to guidelines. While 
the study demonstrating this had limited power due to small numbers, the form served to 
prompt practitioners to fulfil PSA requirements (73). A similar approach was also shown to be 
effective for the ED management of asthma (74). While these options may partially address 
the problem, they only represent simplistic solutions to a multifaceted issue.  
The National Institute for Clinical Excellence (NICE) is a program in the National Health Service 
in England and Wales that aims to improve access to and levels of healthcare. In a study 
examining the guidelines laid down by NICE, researchers sought evidence of guideline 
implementation. A number of different areas were targeted, each with differing degrees of 
implementation. More importantly the study explored the facilitators and barriers to 
guideline adoption and adherence. Guidelines that show distinct advantages to adherence are 
evidence-based and have professional endorsement. Procedures requiring a team approach 
were also shown to have higher rates of adherence due to a reduced allowance for 
autonomy. Organisational factors, such as an organisational culture of commitment to NICE, 
the degree to which administrators included healthcare institutions in the process of 
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implementation, the degree to which the program was prioritised at the point of care, funding 
needs, and consultant support, also influenced implementation. (75) 
A systematic review by Cabana et al. (66) further enhances one’s understanding of 
practitioner adherence. All variables may be categorised into three central themes, these 
being knowledge, attitude and behaviour factors. Familiarity and awareness of guidelines 
were measures of knowledge, degree of agreement, outcome expectancy and self-efficacy 
and motivation were indicative of attitude, and external barriers namely patient, guideline 
and environmental factors were measures of behaviour. (66) While some of these variables 
are in common with the Awareness – to – Adherence model (60) the addition of 
environmental factors, such as lack of resources or patient preference, provides a more 
holistic  view of adherence (66). The implication of this is that strategies to improve 
adherence can be appropriately tailored to address specific issues, rather than attempting to 
solve the problem blindly. 
2.10 Summary 
PSA offers a number of advantages as evidenced by its growth in use. This growth, however, 
has been accompanied by complication rates that are unacceptable thereby motivating the 
development of practice guidelines by anaesthesia and other specialities. These serve to assist 
practitioners to provide safe care; however, the literature has revealed a gap between 
guideline development and adherence. The factors affecting adherence are many due to the 
complexity of the issue, but assist in our understanding of the problems around PSA. With this 
insight, guided solutions may be better applied. 
In this chapter the literature pertaining to PSA, its safe administration and the factors 
influencing PSA guideline adherence have been discussed. In the following chapter the study 
methodology is presented.  
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 Chapter Three  Research Methodology 
3.1 Introduction 
This chapter consists of the problem statement, aims and objectives, ethical considerations, 
research design and methodology that was followed and a discussion of validity and reliability 
of the study. 
3.2 Problem statement 
The doctors at CHBAH make use of PSA techniques in a number of departments; however, it 
has been observed that the regulations formulated by SASA to ensure the safe performance 
of PSA are unfamiliar to some health care professionals involved. Furthermore, it is doubted 
that anyone has ascertained whether the recommended drugs and equipment required for 
the safe delivery of PSA are available. 
The perceived consequences of these inadequacies are that PSA is being provided by 
personnel not qualified in PSA, and may lack the necessary knowledge and skill to offer a safe 
procedure by being ill-equipped to deal with possible complications that may arise. In 
addition, procedural and emergency drugs and equipment may not be available. This places 
patients at an increased risk of adverse events. 
3.3 Purpose 
The purpose of this research is to assess the profile of non-anaesthesiologist PSA providers at 
CHBAH, their awareness of the SASA Sedation Guidelines 2010 and their level of comfort 
when performing PSA. The available equipment and drugs in PSA settings outside the 
operating theatre complexes was also assessed. 
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3.4 Objectives 
The objectives of the study were to: 
 describe the professional level of respondents 
 describe respondent PSA and resuscitation training 
 describe the locations and procedures for which PSA is performed 
 assess the level of awareness of PSA guidelines (SASA) 
 describe the comfort level of practitioners when performing PSA 
 compare the level of PSA knowledge by professional level 
 compare the level of PSA knowledge by clinical department 
 compare the level of comfort by professional level 
 audit the availability of recommended drugs and equipment. 
3.5 Ethical considerations 
Verbal assent was obtained from the heads of departments of general surgery, trauma, 
radiology, emergency medicine, orthopaedic surgery prior to the proposal being submitted to 
the Human Research Ethics Committee (Medical) of the University of the Witwatersrand. This 
was done in order to gauge whether the study would be acceptable to these departments. 
Assent from the department of Internal Medicine was obtained subsequent to ethics 
approval. 
Ethics approval has been obtained from the Human Research Ethics Committee (Medical) 
(Appendix 1) and the Post-Graduate Committee of the University of the Witwatersrand 
(Appendix 2). Permission was also granted by the CHBAH Medical Advisory Committee 
(Appendix 3). 
Subsequently, written assent was sought from the Heads of Departments of general surgery, 
trauma, radiology, emergency medicine, orthopaedic surgery and internal medicine 
(Appendix 4).  
Upon assent from the listed departments, a self-administered questionnaire was distributed 
to potential participants. The questionnaire contained an information letter (Appendix 5) 
detailing the purpose of the study, ethics and CHBAH approval and the rights of participants 
to anonymity and withdrawal. The agreement to complete the questionnaire (Appendix 6) 
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implied consent. Anonymity of participants and questionnaires was ensured by not recording 
participants’ names on the questionnaires and once questionnaires were collected from the 
various departments, they were all placed together for data collection. Furthermore, 
confidentiality was ensured as the researcher and supervisors were the only people who had 
access to the raw data.  
The study was conducted in adherence to the principles of the Declaration of Helsinki (18). 
3.6 Research methodology 
3.6.1 Research design 
A prospective, descriptive, contextual study design was used.  
A prospective study is defined as a study in which the variables will be measured at the time 
in which the study takes place (76). This study was prospective in that a group of doctors was 
identified for study and the data was collected from them during the course of the study. 
A descriptive study aims to describe a situation or identify problems through observation, 
description or classification without manipulating variables (76, 77). No treatment or 
intervention is tested (77). This study was descriptive in design in that it planned to provide 
new information on the study variables defined in the objectives. 
A contextual study is one that takes place in a specific location (77). This study was contextual 
as it was conducted at one hospital only, namely CHBAH. This may impact the validity of the 
study by limiting one’s ability to generalise results.  
3.6.2 Study population 
Doctors working in the general surgery, trauma, radiology, emergency medicine, orthopaedic 
surgery and internal medicine departments belonging to the professional levels second year 
intern, community service officer, medical officer, registrar and consultant formed the 
population group studied. All interns in their second year of internship were selected as they 
would have had sufficient exposure to PSA during their clinical rotations in their first year. It is 
acknowledged that some of these interns will have rotated through anaesthesia, and would 
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have had some formal exposure to sedation practice. First year interns were thus identified 
prior to distribution of questionnaires and were excluded as their exposure to PSA would be 
limited.   
3.6.3 Study sample 
Sample size 
All doctors in the departments were identified and eligible to participate. A sample was 
realised from the number of respondents. 
Sampling method 
All professional levels within the departments were identified with the assistance of the 
departmental secretaries. A list with all the names of the members of that department was 
provided. A convenience sampling method was used for registrars as this group of doctors 
rotate amongst three academic hospitals affiliated to the University of the Witwatersrand. 
Registrars who were rotating through CHBAH at the time of the study were selected. Thus, a 
convenience sampling method was used for this professional level as only the registrars who 
were rotating through CHBAH at the time of the study were identified and were eligible to 
participate in the study.  
Inclusion and exclusion criteria 
Inclusion criteria 
 Medical doctors from the departments of general surgery, trauma, radiology, 
emergency medicine, orthopaedic surgery and internal medicine 
 Professional levels intern, community service officer, medical officer, registrar and 
consultant. 
Exclusion criteria 
 Medical doctors who indicated that they have never been involved in the 
administration of PSA at CHBAH. 
 First year interns 
 Medical doctors who declined to participate. 
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3.6.4 Data collection  
Data collection was done with the use of two tools: a self-administered questionnaire and an 
equipment and drugs audit checklist.  
Self-administered questionnaire (Appendix 6) 
Questionnaire development 
In order to develop a questionnaire that would accurately assess awareness of procedural 
sedation guidelines amongst doctors a review of the literature was done. The questionnaire 
used by Fanning (72) for her study: Monitoring during sedation given by non-anaesthetic 
doctors, served as a foundation for the questionnaire.  Furthermore, search terms such as 
“awareness”,” knowledge” and “comfort” were included in the search. A few of the studies 
reviewed included their questionnaires and these served as a guide. Other studies did not 
include their questionnaires but the questions could be inferred from the results provided.   
In addition a detailed review of the 2010 SASA Guidelines for the provision of PSA to adults 
was done as these would form the reference point for assessing PSA guideline awareness. The 
reasons for choosing the SASA Guidelines were that these guidelines were the most 
comprehensive guidelines available at the time of questionnaire development, they have 
been specifically developed for use by non-anaesthesiologists and the researcher is 
specialising in anaesthesiology, and thus follows the guidelines set by the speciality. It is 
however recognised, that guidelines have been developed by other specialities that perform 
PSA, and that the use of these speciality-specific guidelines supersedes those developed by 
SASA. After reviewing many of the guidelines, it was found that a great deal of common 
ground exists between them, but that the SASA guidelines are indeed, the most 
comprehensive. 
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With the study objectives in mind the questionnaire assessed the following items: 
 professional level 
 locations where PSA was performed 
 procedures for which PSA was performed 
 awareness of PSA guidelines 
 PSA practices 
 PSA-specific pharmacology knowledge 
 comfort levels when performing PSA 
The questionnaire was validated by four experts, with a special interest in pain, from the 
department of Anaesthesiology, University of the Witwatersrand. This was done in order to 
ensure content and face validity. 
Scores for questions assessing guideline knowledge or awareness were awarded one score for 
a correct answer and a zero score for an incorrect answer. Unanswered questions will also be 
awarded a zero score.  
Questionnaire distribution 
Once approval to conduct the study was obtained from the Human Research Ethics 
Committee (Medical) of the University of the Witwatersrand the Heads of Departments of 
general surgery, trauma, radiology, emergency medicine, orthopaedic surgery and internal 
medicine were approached for written assent to conduct data collection in their respective 
departments.  
Once assent as well as consent from the CHBAH Medical Advisory Committee was obtained, 
all medical doctors that fit the inclusion criteria within the departments were identified with 
the assistance of the departmental secretary. A list with all the names of the members of that 
department was provided and an indication of appropriate times to approach these medical 
doctors was sought, e.g. departmental meetings. 
The questionnaires, contained within a box, were distributed during departmental meetings 
to those medical doctors who agreed to participate in the study. Furthermore, visits to the 
wards and theatre were made in order to offer as many doctors as possible the opportunity to 
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participate. Upon collection of a questionnaire, that participant was marked off the list that 
the departmental secretary had supplied and kept in a box to which only the researcher and 
supervisors had access. This was not possible in all cases, where questionnaires were 
completed and returned to a box placed in the secretary’s office.  
Equipment and drugs audit (Appendix 7) 
The assent and consent procedures have been outlined above and include the audit of PSA 
locations. These have been identified and suitable times to perform the audit were identified 
with the Heads of Department responsible for that location. Each of these areas was audited 
according to the SASA Basic Equipment and Drugs for Procedural Sedation and Analgesia 
(PSA) (3) checklist (Appendix 7).  
All data obtained from both the questionnaire and the audit was captured onto an Excel 
spread sheet for analysis. Quality control checks were performed to ensure accuracy.  
The data collection process may be seen in Figure 3.1.  
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Figure 3.1  Data collection process flow 
 
 
 
 
3.7 Data analysis 
Data was analysed using descriptive and inferential statistics using Microsoft Excel. For 
descriptive analysis of data that were normally distributed, mean and standard deviation (SD) 
was used. After consultation with a bio-statistician the assumptions for ANOVA (equal 
variance and normality) were tested and met. Bonferroni testing and correction procedure 
was used for post-testing to identify where the significant differences lie. A p-value of less 
than 0.05 was considered to be statistically significant. 
3.8 Validity and reliability 
Validity of the study was ensured by: 
 Representative sample size – all professional levels were approached to participate in 
the study. The results may thus be generalised.  
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 Selection bias was minimised by approaching all doctors involved in PSA at CHBAH. 
Convenience sampling was, however, applied to registrars, and thus those registrars 
at CHBAH at the time of the study were selected. This was not expected to reduce 
validity as these registrars are likely to be representative of this group of doctors. 
 Consent and instrument validation processes. A panel of four anaesthesiologists, with 
a sub-speciality in pain, were involved in questionnaire development.  
 Criterion-related validity. Instruments used in similar studies were used as a 
comparison for the development of the questionnaire.  
A potential threat to validity was the possibility that Heads of Department may have tried to 
improve the equipping of PSA locations in anticipation of the study.   
Reliability of the study was ensured by: 
 Consistency has been ensured through a validation process by ensuring that items on 
the questionnaire measure the intended variables; 
 The questionnaire was developed following a literature review. In addition the 
questionnaire was assessed by four consultant anaesthesiologists, with a special 
interest in pain. This ensured the reliability of the questionnaire. 
3.9 Summary  
This chapter has described the research methodology employed in this study. This includes: 
the research question; the aims and objectives of this study; the ethical considerations 
encountered in the conduct of this study; detailed the research design; the description of the 
population and samples used; discussed the data collection methods; data analysis used and 
reliability and validity  
In the next chapter, the results of this study are presented. 
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 Chapter Four  Results 
4.1 Introduction  
This chapter contains the results of the data collected and are presented according to the 
objectives stated in chapter one. 
The objectives of the study were to: 
 describe the professional level of respondents 
 describe respondent PSA and resuscitation training 
 describe the locations and procedures for which PSA is performed 
 assess the level of awareness of PSA guidelines (SASA) 
 describe the comfort level of practitioners when performing PSA 
 compare the level of PSA knowledge by professional level 
 compare the level of PSA knowledge by clinical department 
 compare the level of comfort by professional level 
 audit the availability of prescribed drugs and equipment. 
4.2 Sample realisation 
The study was conducted from October 2012 to January 2013. All professional levels were 
eligible to participate with the exception of first year interns. Doctors were identified with 
lists provided by departmental secretaries and interns were excluded prior to questionnaire 
distribution. Questionnaires were distributed to the departments of general surgery and 
trauma, radiology, emergency medicine, orthopaedic surgery and internal medicine. This was 
done at departmental meetings. The researcher attended one meeting in the departments of 
emergency medicine and general surgery and trauma. Doctors who were not present at the 
meetings were then sought out to offer them an opportunity to participate. Numerous 
meetings needed to be attended in the Department of Orthopaedic Surgery in order to 
ensure that most doctors within this department had an opportunity to participate.  
The attendance of departmental meetings was not possible in two departments. In one of 
these departments a box containing the questionnaires was placed in the administration 
office. The departmental secretary distributed and collected questionnaires from the doctors 
who came into her office. In the second department, academic meetings were held at the 
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Charlotte Maxeke Johannesburg Academic Hospital. This made administration of the 
questionnaires to the CHBAH doctors alone very difficult. For this reason the researcher went 
to the department during tea-times to explain and distribute the questionnaires. Doctors 
were also sought out in order to offer as many as possible the opportunity to participate. 
Electronic questionnaires were emailed to members of that department upon their request. A 
box containing questionnaires was also placed in the administration office for collection.  
Questionnaires were distributed to the interns within the above-mentioned departments. 
Those rotating through other departments at the time of collection were individually sought.  
In addition questionnaires were emailed to those interns placed at peripheral clinics at the 
time of data collection. 
A total of 359 doctors worked for the departments, as identified by the lists provided by 
departmental secretaries. It is uncertain how many of these doctors were approached, 
however, a total of 160 doctors agreed to participate and completed questionnaires. Of the 
questionnaires returned, one questionnaire was excluded as the respondent indicated that he 
did not perform PSA. The total number of respondents was thus 159.  
4.3 Results 
The results of the questionnaires collected and the equipment and drug audit are presented 
below. Descriptive and inferential statistics are used to analyse the data and percentages will 
be rounded off to two decimal places. One point was awarded for a correct answer and no 
point was awarded for an incorrect or unanswered question.  
4.3.1 Demographics 
Of the 159 respondents, 65 (40.88%) were female and 93 (58.49%) were male. One 
respondent did not complete this question.   
The departmental breakdown of the number of people who chose to respond is shown in 
Figure 4.1. Thirty seven (23.27%) respondents were from the department of general surgery 
and trauma. Nineteen (11.95%) respondents were from the department of orthopaedic 
surgery. Twenty (12.58%) respondents were from the department of emergency medicine. 
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Fourteen (8.81%) respondents were from the department of radiology. Twenty two (13.84%) 
respondents were from the department of internal medicine. Fourty seven (29.56%) 
respondents did not answer this question (blank), 46 of whom were interns who do not 
belong to any one department. This question was not applicable to 46 respondents as they 
were second year interns. They constitute 46 of the 47 respondents who did not complete 
this question. One other respondent did not complete this question. 
Figure 4.1  Departmental breakdown of respondents 
 
 
 
There were 37 completed questionnaires from the department of general surgery and 
trauma. This constituted 77.08% of this department. The department of orthopaedic surgery 
returned 19 (41.30%) completed questionnaires, emergency medicine returned 20 (100%), 
radiology returned 14 (37.84%) and internal medicine returned 22 (18.33%) completed 
questionnaires.  
The results relating to the objectives outlined above will now be discussed. For continuity the 
relevant questions from the questionnaire will be placed in the results.  
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4.3.2 Professional level of PSA practitioners  
The first objective of the study was to describe the professional level of respondents. Thirty 
eight (23.90%) consultants, 52 (32.70%) registrars, 21 (13.21%) medical officers, one (0.63%) 
community service doctor and 46 (28.93%) interns participated in the study (Figure 4.2).  
Figure 4.2  Professional levels of respondents 
 
 
 
 
4.3.3 Describe respondent PSA and resuscitation training 
The second objective of the study was to describe the training of respondents after 
attainment of their medical degrees. One hundred and thirteen (70.63%) respondents 
indicated they had completed BLS, 97 (60.63%) respondents ACLS, 25 (15.63%) PSA 
training/lectures/workshops and 40 (25%) indicated they had done other forms of training.  
In addition, respondents were asked whether they thought they would benefit from PSA 
training, the results of which are shown in Figure 4.3. One hundred and twenty seven 
(79.87%) respondents indicated that they would benefit from PSA training, 6 (3.77%) 
indicated that they would not benefit and 20 (12.58%) responded that they didn’t know. Six 
(3.77%) respondents did not answer this question.  
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Figure 4.3  Benefit from PSA training 
 
 
 
 
4.3.4 Describe the locations and procedures for which PSA is performed 
The third objective of the study was to describe the locations and procedures for which PSA is 
performed. PSA locations are displayed in Figure 4.4. “Other” was an option on the 
questionnaire and this was indicated by six (3.77%) respondents.  
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Figure 4.4  PSA locations 
 
 
 
The procedures for which PSA are performed was also assessed. Sixty nine (43.43%) 
respondents indicated they use PSA for incision and drainage procedures, 73 (45.91%) for 
suturing, 71 (44.65%) for orthopaedic procedures, 49 (30.82%) for radiological procedures, 46 
(28.93%) for endoscopy, 84 (52.83%) for the insertion of intercostal drains, 40 (25.16%) for 
cardioversion and 36 (22.64%) indicated “other”. “Other” procedures specified by 
respondents included bone marrow aspirate and trephine (12), central venous access (4), 
lumbar puncture (4), and endotracheal intubation (3), Quinton line insertion (2), pleural tap 
(2). Procedures listed by no more than one respondent included dressing changes, Tenckhoff 
catheter insertion, percutaneous endoscopic gastrostomy tube insertion, liver biopsy, fine 
needle aspirates, minor theatre.  
4.3.5 Level of awareness of PSA guidelines (SASA) 
The fourth objective of the study, levels of awareness of PSA guidelines, was assessed in two 
sections. 
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Section 1  
The first section assessed guideline awareness with specific focus on knowledge and use of 
guidelines, permitted scope of PSA practice and PSA monitoring requirements.  
Respondents were asked about the presence of a protocol for sedation practices in their 
departments. As shown in Figure 4.5, 117 (73.59%) respondents indicated that they were not 
at all aware of a protocol for sedation practices in their departments, 16 (10.06%) indicated 
that they had heard about them, 9 (5.66%) were familiar with their content and 15 (9.43%) 
use them when performing PSA. Two (1.26%) respondents did not answer this question. 
Figure 4.5  PSA guideline awareness 
 
 
 
Respondents were also asked if they were aware of which PSA protocol was in use in their 
departments. Thirteen (8.18%) indicated that SASA Guidelines were used, seven (4.40%) 
indicated Emergency Medicine Society of South Africa, Procedural sedation in the emergency 
centre were in use, four (2.52%) indicated AGA and eight (5.03%) indicated that other 
guidelines were in use. One respondent stated that he was aware that a protocol was in use 
but was unsure which one. 
Respondents were then asked questions to assess detailed knowledge of the SASA Guidelines.  
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The number of medical personnel required for minimal sedation/anxiolysis was answered 
correctly by 109 (68.55%) respondents and incorrectly by 50 (31.45%). 
Pre-sedation recommendations were assessed by providing a number of options to 
respondents. Fourteen (8.81%) respondents correctly marked all three of the appropriate 
options. Thirty nine (24.53%) correctly marked two and 81 (50.94%) marked one option 
correctly. Twenty five respondents (15.72%) did not mark anything for this question. 
A non-anaesthesiologist is permitted to give PSA to ASA grades I and II. This was correctly 
indicated by 82 (51.57%) respondents. Forty nine (30.82%) respondents correctly indicated 
one correct option and 28 (17.61%) did not answer this question. No one indicated an ASA 
level of III or more.  
Respondents were asked to indicate the appropriate monitoring required for PSA. Fifty eight 
(36.48%) respondents correctly indicated all five PSA monitoring requirements. Fifty four 
(33.96%) respondents correctly indicated 4 of 5 correct answers, 27 (16.98%) correctly 
indicated 3 of 5 correct answers, 16 (10.06%) correctly indicated 2 of 5 correct answers, 1 
(0.63%) correctly indicated 1 of 5 correct answers and 3 (1.89%) did not mark anything 
correctly for this question. 
Respondents were asked to indicate the required PSA Emergency equipment. Ninety six 
(60.38%) respondents correctly indicated all five emergency equipment requirements,  43 
(27.04%) respondents correctly indicated 4 of 5 correct answers, 8 (5.03%) correctly indicated 
3 of 5 correct answers, 7 (4.40%) correctly indicated 2 of 5 correct answers, 2 (1.26%) 
correctly indicated 1 of 5 correct answers and 3 (1.89%) did not mark anything correctly for 
this question.  
The mean score for guideline knowledge was 11.54 (72.13%), with a standard deviation of 
2.58 (16.13%). 
Section 2 
The second section assessed guideline awareness with specific focus on the pharmacology for 
PSA. Respondents were asked to indicate the drugs they use for PSA. This is illustrated in 
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Figure 4.6. “Other” refers to other drugs that respondents may use and was an option on the 
questionnaire and this was indicated by five (3.14%) respondents.  
Figure 4.6  Drugs used for PSA 
 
 
 
One hundred and thirty nine (87.42%) respondents correctly answered that when using more 
than one class of drug for PSA one should administer the medication in divided doses titrated 
to effect. Twenty (12.58%) respondents did not answer this question correctly.  
The dose of midazolam was correctly answered by 59 (37.11%) respondents, and incorrectly 
answered by 100 (62.89%) respondents.  
The side effects of midazolam were assessed with five true/false/don’t know statements. 
Eleven (6.92%) respondents correctly answered all 5 statements. Thirty two (20.13%) 
answered 4 of 5 correctly, 46 (28.93%) answered 3 of 5 correctly, 41 (25.79%) answered 2 of 5 
correctly, 17 (10.69%) answered 1 of 5 correctly and 12 (7.55%) left this question blank.  
The side effects of ketamine were assessed in a similar way. Twenty six (16.35%) respondents 
answered all 5 statements correctly, 25 (15.72%) answered 4 of 5 correctly, 31 (19.50%) 
answered 3 of 5 correctly, 33 (20.75%) answered 2 of 5 correctly, 15 (9.43%) answered 1 of 5 
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correctly and 29 (18.24%) did not answer anything correctly for this question. One respondent 
wrote that he does not know about ketamine and for this reason does not use it.  
One hundred and twenty one (76.10%) respondents correctly stated that opioid induced 
respiratory depression is dose dependent, while 38 (23.90%) incorrectly answered this 
question.  
The correct dose of naloxone was indicated by 38 (23.90%) respondents, while 121 (76.10) 
incorrectly answered this question. 
Ninety one (57.23%) respondents correctly answered “false” for the use of opioids for their 
sedative effect for painless procedures and 68 (42.77%) incorrectly answered this question.   
The mean score for pharmacology knowledge was 8.01 (53.40%) with a standard deviation of 
3.14 (20.93%).  
The mean score for both guideline knowledge and pharmacology was 19.55 (63.06%) with a 
standard deviation of 4.75 (15.32%).  
4.3.6 Levels of comfort of PSA practitioners  
The fifth objective of the study was to describe the level of comfort of practitioners when 
performing PSA, and is illustrated in Figure 4.7 
When administering PSA, seven (4.40%) respondents indicated they feel very comfortable 
when administering PSA, 44 (27.67%) feel comfortable, 61 (38.36%) neutral, 42 (26.42%) 
uncomfortable and three (1.89%) feel very uncomfortable. Two (1.26%) respondents did not 
answer this question. 
With regard to identifying complications related to PSA eight (5.03%) respondents indicated 
they feel very comfortable, 71 (44.65%) feel comfortable, 45 (28.30%) feel neutral, 27 
(16.98%) feel uncomfortable and 6 (3.77%) feel very uncomfortable. Two (1.26%) respondents 
did not answer this question.  
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With regards to managing complications related to PSA nine (5.66%) respondents indicated 
they feel very comfortable, 50 (31.45%) respondents feel comfortable, 57 (35.85%) feel 
neutral, 32 (20.13%) feel uncomfortable and 9 (5.66%) feel very uncomfortable. Two (1.26%) 
respondents did not answer this question.  
Figure 4.7  Levels of comfort performing PSA   
 
 
 
It was found that 110 (69.18%) respondents feel that they are able to object to administering 
PSA if they feel uncomfortable. 29 (18.24%) respondents indicated they were not able to 
object, 17 (10.69%) were unsure and three (1.89%) did not answer this question.  
4.3.7 PSA knowledge by professional level 
The sixth objective of the study was to compare the level of knowledge of PSA among the 
different professional levels. 
After consultation with a bio-statistician the assumptions for ANOVA (equal variance and 
normality) were tested and met. Bonferroni testing and correction procedure was used for 
post-testing to identify where the significant differences lie.  
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For the purposes of comparison professional levels were divided into three groups. 
Consultants and registrars each formed one group and medical offices, community service 
doctors and interns (MO/CS/I) were combined to form the third group. These professional 
levels were combined as they are all pre-specialisation and are not part of a formal academic 
program.  
Knowledge was assessed in two sections, namely guideline knowledge and pharmacology 
knowledge. For guideline knowledge a statistically significant difference was found between 
the groups ANOVA (F [2, 155]=5.40, p=0.0054). The MO/CS/I group performed better than the 
consultant group (p=0.008) with mean scores of 12.26 (76.63%) and 10.71 (66.94%) 
respectively. Registrars achieved a mean score of 11.19 (69.94%) but no statistically significant 
difference was found between this group and consultants (p=1.00) or the MO/CS/I group 
(p=0.065).  
For pharmacology knowledge, no statistically significant difference was found between the 
groups ANOVA (F [2, 155]=1.67, p=0.19). Consultants achieved a mean score of 7.21 (48.07%), 
registrars achieved a mean score of 8.33 (55.53%) and the MO/CS/I group achieved a mean 
score of 8.22 (54.80%).  
A total knowledge score was also calculated and a statistically significant difference was found 
between the groups ANOVA (F [2, 155]=3.67, p=0.027). The MO/CS/I group once again 
performed better than the consultant group (p=0.02), with mean scores of 20.50 (66.08%) 
and 17.92 (57.81%) respectively. Registrars achieved a mean score of 19.5 (62.97%) but no 
statistically significant difference was found between this group and consultants (p=0.33) or 
the MO/CS/I group (p=0.79). The performance of each professional level for guideline, 
pharmacology and total knowledge is shown in Figure 4.8.  
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Figure 4.8  Levels of knowledge according to professional level   
 
 
 
 
4.3.8 PSA knowledge by clinical department 
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Table 4.1  Guideline and pharmacology knowledge per department 
 
  Knowledge (mean (SD) %) 
  Guideline Pharmacology Total 
C
lin
ic
al
 d
ep
ar
tm
e
n
ts
 Radiology (n=14) 10.21 (2.55) 63.81 6.21 (3.36) 41.40 16.43 (4.80) 53.00 
Orthopaedics (n=19) 9.89 (3.41) 61.81 6.58 (2.59) 43.87 16.47 (5.28) 53.13 
General surgery/trauma 
(n=37) 
11.05 (2.86) 69.06 8.19 (3.22) 54.60 19.24 (4.77) 62.06 
Internal medicine (22) 11.45 (2.42) 71.56 7.86 (3.23) 52.40 19.32 (4.58) 62.32 
Emergency medicine (20) 12.45 (1.50) 77.81 9.20 (3.37) 61.33 21.65 (4.25) 69.84 
  
For guideline knowledge a statistically significant difference was found between the 
departments ANOVA (F [4, 107]=2.76, p=0.0314). The emergency medicine department 
performed better than the orthopaedic surgery department (p=0.03) with mean scores of 
12.45 (77.81%) and 9.89 (61.81%) respectively. 
For pharmacology knowledge, ANOVA testing suggested a statistically significant difference 
existed between the groups ANOVA (F [4, 107]=2.70, p=0.034); however, Bonferroni testing 
and correction procedure failed to show a difference between the departments. This is 
possible due to under-powering as the sample size was not calculated to find this difference.  
Calculation of the total knowledge score showed a statistically significant difference between 
the departments ANOVA (F [4, 107]=3.97, p=0.0048). These differences were found between 
the departments of radiology and emergency medicine (p=0.02), with mean scores of 16.43 
(53.00%) and 21.65 (69.84%) respectively. A statistically significant difference was also found 
between the departments of orthopaedic surgery and emergency medicine (p=0.009), with 
mean scores of 16.47 (53.13%) and 21.65 (69.84%) respectively. 
4.3.9 Levels of comfort between the different professional levels  
The eighth objective of the study was to compare the level of comfort when performing PSA 
among the different professional levels. The levels of comfort were grouped into three 
categories. Very comfortable and comfortable formed one category, neutral formed the 
second category and uncomfortable and very uncomfortable formed the third category. Table 
4.2 shows the number of respondents per professional level and their respective levels of 
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comfort when administering drugs for PSA. Three respondents did not indicate there 
professional level and so they were excluded from the analysis.  
Table 4.2  Level of comfort per professional level when administering drugs for PSA   
 
  Professional Level 
  Consultant 
(36) 
Registrar 
 (52) 
MO/CS/I 
(68) 
Le
ve
ls
 o
f 
co
m
fo
rt
 Comfortable 19 (52.78%) 16 (30.77%) 16 (23.53%) 
Neutral 10 (27.78%) 23 (44.23%) 27 (39.71%) 
Uncomfortable 7 (19.44%) 13 (25.00%) 25 (36.76%) 
  
A Pearson χ2 test was performed and showed a statistically significant difference (p=0.031) 
existed between the groups. This difference was found between the MO/CS/I group and the 
consultant group, where 36.76% of the MO/CS/I group, in contrast to 19.44% of the 
consultant group, indicated they felt uncomfortable administering PSA. No other statistically 
significant difference between the groups was found.  
Table 4.3 shows the number of respondents per professional level and their respective levels 
of comfort when identifying complications related to PSA. 
Table 4.3  Level of comfort per professional level identifying PSA complications   
 
  Professional Level 
  Consultant 
(36) 
Registrar 
 (52) 
MO/CS/I 
(68) 
Le
ve
ls
 o
f 
co
m
fo
rt
 Comfortable 21 (58.33%) 29 (55.77%) 29 (42.65%) 
Neutral 6 (16.67%) 15 (28.85%) 23 (33.82%) 
Uncomfortable 9 (25.00%) 8 (15.38%) 16 (23.53%) 
 
 
Analysis with a Pearson χ2 test showed no statistical significant difference between the groups 
for this question (p=0.26).  
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Table 4.4 shows the number of respondents per professional level and their respective levels 
of comfort managing complications related to PSA. 
Table 4.4  Level of comfort per professional level managing PSA complications   
 
  Professional Level 
  Consultant 
(36) 
Registrar 
 (52) 
MO/CS/I 
(68) 
Le
ve
ls
 o
f 
co
m
fo
rt
 Comfortable 20 (55.56%) 24 (46.15%) 15 (22.06%) 
Neutral 8 (22.22%) 17 (32.69%) 31 (45.59%) 
Uncomfortable 8 (22.22%) 11 (21.15%) 22 (32.35%) 
 
 
Analysis with a Pearson χ2 test showed a statistically significant difference (p=0.008) between 
the groups. Fifty five point five six percent of the consultant group, in contrast to 22.26% of 
the MO/CS/I group, indicated they felt comfortable managing complications related to PSA. In 
addition a larger proportion (45.59%) of the MO/CS/I group felt neutral compared to the 
consultant group (22.22%). 
The greatest proportion of respondents felt they could object to the administration of PSA in 
all three groups. The largest proportion of respondents that felt they could not object was the 
MO/CS/I group (23.53%). This is in contrast to 16.67% in the consultant groups and 13.46% in 
the registrar group. Despite these findings, analysis with a Pearson χ2 test showed no 
statistical significant difference between the groups (p=0.32).  
Lastly, a relationship between knowledge and level of comfort was examined. No statistically 
significant relationship was found between guideline knowledge ANOVA (F [2, 154]=0.69, 
p=0.50), pharmacology knowledge ANOVA (F [2, 154]=0.84, p=0.44), or overall knowledge 
ANOVA (F [2, 154]=0.89, p=0.41), and the level of comfort when administering drugs for PSA.  
A statistically significant relationship was found between pharmacology knowledge and the 
level of comfort identifying complications related to PSA, with the comfortable group scoring 
8.63 (57.55%) and the uncomfortable group scoring 7.03 (46.87%) ANOVA (F [2,154]=3.40, 
p=0.036). 
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In addition a statistically significant relationship was found between pharmacology knowledge 
and the level of comfort managing complications related to PSA ANOVA (F [2,154]=4.42, 
p=0.014).  The comfortable group scored 8.97 (59.77%) and the uncomfortable group scored 
7.27 (48.46%). 
4.3.10 Audit of the availability of prescribed drugs and equipment 
The ninth objective of the study assessed the equipment and drugs available in the locations 
in which PSA is performed. This audit was based upon the list provided in the SASA guidelines.   
The following areas were assessed: CT scan rooms 1 and 2, medical casualty, endoscopy 
suites, ERCP suite, emergency medicine department, surgical casualty, trauma casualty and 
resuscitation area, and the orthopaedic casualty procedure room. The overall percentage of 
expected equipment and drugs available in these areas is shown in Figure 4.9. 
Figure 4.9  Equipment and drug availability in different PSA locations   
 
 
 
The checklist is divided into components. The availability of devices to administer oxygen and 
assist with ventilation was found to be 63.64% in CT scan room 1, 72.73% in CT room 2, 
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81.82% in the emergency medicine department, 18.18% in the surgical casualty, 81.82% in the 
trauma casualty and resuscitation area, and 0% in the orthopaedic casualty procedure room. 
The availability of airway devices and equipment was found to be 63.64% in CT scan room 1, 
72.73% in CT scan room 2, 81.25% in the medical casualty, 81.25% in the endoscopy suites, 
72.73% in the ERCP suite, 81.25% in the emergency medicine department, 18.18% in the 
surgical casualty, 81.25% in the trauma casualty and resuscitation area, and nil in the 
orthopaedic casualty procedure room.    
The availability of monitoring equipment was found to be 12.50% in CT scan room 1, 50.00% 
in CT scan room 2, 62.50% in the medical casualty, 50.00% in the endoscopy suites, 50.00% in 
the ERCP suite, 75.00% in the emergency medicine department, 37.50% in the surgical 
casualty, 75.00% in the trauma casualty and resuscitation area, and 0% in the orthopaedic 
casualty procedure room.  
The availability of equipment with which to gain intravenous access was found to be 66.67% 
in CT scan room 1, 88.89% in CT scan room 2, 77.78% in the medical casualty, 77.78% in the 
endoscopy suites, 77.78% in the ERCP suite, 88.89% in the emergency medicine department, 
88.89% in the surgical casualty, 88.89% in the trauma casualty and resuscitation area, and nil 
in the orthopaedic casualty procedure room.  
The availability of equipment for the accurate infusion of drugs and fluids was found to be 
50.00% in CT scan room 1, 2, the endoscopy suites and the ERCP suite. Availability in the 
medical casualty, emergency medicine department, surgical casualty and the trauma casualty 
and resuscitation area was found to be 66.67%, and 16.67% in the orthopaedic casualty 
procedure room.  
The availability of hardware and miscellaneous equipment was found to be 45.45% in CT scan 
room 1, 2 and endoscopy suites, 63.64% in the medical casualty and surgical casualty, 54.55% 
in the ERCP suite, 81.82% in the emergency medicine department, 72.73% in the trauma 
casualty and resuscitation area, and 18.18% in the orthopaedic casualty procedure room.  
The availability of the recommended drugs was found to be 53.85% in CT scan room 1 and 2, 
84.62% in the medical casualty and trauma casualty and resuscitation area, 46.15% in the 
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endoscopy suites, 38.46% in the ERCP suite, 92.31% in the emergency medicine department, 
38.46% in the surgical casualty and 0% in the orthopaedic casualty procedure room.  
4.4 Discussion 
The proportion of doctors for each professional level is a reflection of the level of hospital at 
which the study was performed. CHBAH is a teaching/academic hospital and for this reason, 
consultants, registrars and interns form the majority of the doctor workforce. Registrars 
constituted the greatest proportion of participants (32.70%). This mirrored the study by 
Fanning (72), which was conducted at the university teaching hospitals in Dublin, Ireland. 
Posts for community service doctors at CHBAH are limited or unavailable as these doctors are 
sent to secondary and peripheral hospitals, thereby explaining the single community service 
doctor who participated in the study.  
According to the SASA Guidelines, sedationists are required to have a registered medical 
degree, BLS, ACLS training as well as current knowledge and skill in PSA and its complications 
(3). All respondents were presumed to have a registered medical degree as this forms part of 
the conditions for employment as a doctor at the hospital. Most respondents indicated that 
they had received BLS (70.63%) and ACLS (60.63%) training. It is not known, however, if this 
training is current as one is required to requalify every two years.  
The proportion of doctors with PSA training was very low (15.63%). The RCA and Leroy et al. 
(58, 61) have suggested that PSA training within the specialist disciplines is overlooked but 
needs to be incorporated into specialist training in order to reduce PSA related adverse 
events.  
Whilst the number of respondents with PSA training was low, the perceived benefit of PSA 
training was high (79.87%). Similar results were obtained in a Canadian study among 
radiologists (68). Studies have shown that the incorporation of formalised PSA teaching was 
thought to be useful and that training was indeed able to address PSA knowledge gaps among 
EM practitioners (69, 70). For this reason the introduction of formal PSA training within 
specialist departments has the potential to contribute to practitioners’ PSA knowledge.  
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PSA is performed in a number of locations, however the majority of PSA is conducted in the 
surgical and trauma casualties and emergency department. The procedures for which PSA is 
done may be linked to the location, with intercostal drain insertion, suturing and incision and 
drainage procedures being done mainly in these areas. These results are in contrast to those 
found by Fanning (72), where most PSA was conducted in the endoscopy suites (36.94%) and 
minor surgical theatre (34.23%). The difference may be as a result of the greater number of 
trauma-related cases seen at CHBAH and the need to perform procedures in the surgical, 
trauma and emergency departments to relieve pressure on theatre demand. 
 The development of guidelines was done in order to improve standards of care and safety 
however adherence to guidelines is a complex process. Most respondents (73.58%) indicated 
that they were not at all aware of a protocol for sedation practice in their department and 
only 9.43% used them when performing PSA.  While these results are lower than those found 
in other studies (58, 62, 63, 72), the successful implementation of guidelines remains a 
challenging task across specialities. One of the reasons for this may be the tendency to follow 
guidelines developed by ones’ own speciality (62, 71). This was the reason for enquiring about 
the use of guidelines other than those developed by SASA. Specialist affiliation was, however, 
not observed in this study. Other reasons for poor guideline adherence are discussed in 
Pathman et al. (60) awareness – agreement -  adoption model. The impact of these factors 
was not explored in this study, but may serve as a guide for future research. 
Guideline knowledge was assessed with a number of questions concerning correct conduct of 
PSA and monitoring requirements. The low levels of awareness and use of PSA guidelines 
suggests that the mean score of 72.13% is based on knowledge acquired through means other 
than guideline use. When analysing the results further it was found that the MO/CS/I group 
performed better than the consultant group. This was a surprising result as consultants have 
completed their specialist training and would thus be expected to have greater knowledge. A 
possible explanation may be that once doctors have obtained their specialisation, the level of 
knowledge acquisition and retention declines as they are no longer in a structured teaching 
program. Another reason may be that the task of PSA may be assigned to more junior 
doctors, with the result being a decline in PSA knowledge and skill among consultants. 
Guideline knowledge was also found to be greater among EM respondents, with a significant 
different existing between this group and the department and orthopaedic surgery.  
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The most frequently used drug for PSA, in both this study and by Fanning (72), was found to 
be midazolam, with rates of 80.50% and 98.20% respectively. This was followed by local 
anaesthetic agents (65.41%), morphine (64.15%) and ketamine (62.26%), which was in 
contrast to Fanning’s findings of a combination of sedation and local anaesthetic agent 
(82.88%) and sedation and opioid (25.23%) (72). 
The use of propofol for PSA is a debated topic. The SASA guidelines state that only trained 
anaesthesiologists should be using this drug (3), ASA states that those who use it must be 
trained to identify and manage complications that may arise from its use (2), and AGA and the 
field of EM have demonstrated its safe use provided sedationists are adequately trained (13, 
32, 56).  
Twenty eight percent of respondents indicated that they use propofol for PSA yet only 15.63% 
indicated they had received PSA training. This raises safety concerns about the use of drugs 
for which sedationists are not adequately trained to use. While each speciality may follow its 
own guidelines, knowledge of drugs, their complications and management thereof is crucial. 
Pharmacology knowledge was indeed assessed. The mean score was only 53.40%, which 
demonstrates the large pharmacology knowledge gap that exists. Comparison between 
professional levels and departments showed no statistically significant difference. Fanning 
(72) found similarly poor results with a mean pharmacology score of 48.75%. Furthermore, 
19.82% of respondents reported the occurrence of adverse events while administering PSA. 
Anecdotal evidence suggested that PSA practitioners did not feel comfortable performing PSA 
due to the lack of training in this area. The results were confounding as most respondents felt 
neutral with regard to levels of comfort when administering drugs for PSA and managing PSA 
related complications, yet felt comfortable identifying complications. An encouraging finding, 
however, was respondents’ perceived ability to object should they feel uncomfortable 
administering PSA.  
Analysis of levels of comfort according to professional level revealed the MO/CS/I group to be 
the most uncomfortable when administering PSA, whereas the consultant group felt the most 
comfortable managing PSA related complications. Ones’ amount of experience would appear 
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to be a reasonable explanation for this result, with the MO/CS/I group having the least 
experience and years of training.  
A relationship between levels of comfort and knowledge was also sought. It was postulated 
that those who felt more comfortable performing PSA would have greater knowledge. No 
such relationship was found between levels of comfort and guideline knowledge but a 
relationship between levels of comfort identifying and managing complications and 
pharmacology knowledge was found. Those respondents who indicated they felt comfortable 
scored higher than those who indicated they felt uncomfortable, thereby confirming the idea 
that levels of comfort are related to levels of knowledge.  
The drugs and equipment checklist provided by the SASA Guidelines is extremely 
comprehensive. The results indicate many inadequacies, with items missing in each section of 
the checklist. For devices to administer oxygen and assist with ventilation, Venturi and 
nebuliser masks, peak end expiratory pressure (PEEP) valves and catheter mounts were the 
most commonly missing items. In the airway devices and equipment, laryngeal masks and 
nasopharygeal airways were the most commonly missing items. Amongst monitoring 
equipment stethoscopes, thermometers and blood glucose devices were found to be missing 
most often. Equipment for IV access showed deficiencies in sterile gauze pads and 
tourniquets, equipment for drug infusion showed reduced availability of infusion pumps and 
syringe drivers. Amongst hardware and miscellaneous equipment operating tables that could 
be tilted, South African Resuscitation Council Algorithms, procedural documentation and a 
therapeutic heat source were found to be missing.  Drugs most commonly missing were 
flumazenil, ephedrine or phenylephrine, nitroglycerine spray, aspirin, salbutamol and 
suxemethonium.  
While the list of items missing appears to be long, some of these are acceptable as their 
absence does not preclude the safe administration of PSA e.g. the lack of stethoscopes is 
acceptable as most if not all practitioners will have one of their own. While the orthopaedic 
casualty was extremely poorly equipped and the surgical casualty moderately equipped, these 
areas are within close proximity to the trauma resuscitation area and may make use of its 
drugs and equipment if required. Equipment deficiencies that need to be addressed are the 
lack of Venturi and nebuliser masks and the availability of flumazenil, ephedrine or 
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phenylephrine, nitroglycerine spray, aspirin, salbutamol and suxemethonium. In light of the 
high usage of midazolam, flumazenil is of particular importance.  
4.5 Summary 
In this chapter the results of this study have been presented and discussed as per the research 
objectives.  
In the final chapter a summary, the limitations, recommendations and conclusions of the 
study are presented. 
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 Chapter Five  Summary, limitations, recommendations and 
conclusions 
5.1 Introduction 
In this chapter a summary of the objectives, study design and results of the study are 
presented. The limitations of the study will be addressed, recommendations for clinical 
practice and further research made and a conclusion presented. 
5.2 Summary of the study 
5.2.1 Purpose of the study 
The purpose of this research was to assess the profile of non-anaesthesiologist PSA providers 
at CHBAH, their awareness of the SASA Sedation Guidelines 2010 (3) and their level of 
comfort when performing PSA. The available equipment and drugs in PSA settings outside the 
operating theatre complexes was also assessed. 
5.2.2 Objectives of the study 
The objectives of the study were to: 
 describe the professional level of respondents 
 describe respondent PSA and resuscitation training 
 describe the locations and procedures for which PSA is performed 
 assess the level of awareness of PSA guidelines (SASA) 
 describe the comfort level of practitioners when performing PSA 
 compare the level of PSA knowledge by professional level 
 compare the level of PSA knowledge by clinical department 
 compare the level of comfort by professional level 
 audit the availability of recommended drugs and equipment. 
5.2.3 Summary of the methodology used in the study 
A prospective, descriptive, contextual study design was used. Doctors working in general 
surgery, trauma, orthopaedic surgery, radiology, emergency medicine and internal medicine 
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departments belonging to the professional levels consultant, registrar, medical officer, 
community service officer and second year intern formed the population group studied. 
All doctors within the departments were identified.  A convenience sampling method was 
used. The true sample was realised from the number of respondents. 
Data collection was done with the use of two tools: a self-administered questionnaire 
(appendix 6) and the SASA Equipment and Drugs for Procedural Sedation and Analgesia (3) 
checklist (appendix 7). Approval from the Human Research Ethics Committee (Medical) of the 
University of the Witwatersrand, the heads of the departments and CHBAH Medical Advisory 
Committee was obtained. The questionnaire was distributed to those medical doctors who 
agreed to participate in the study. Questionnaires were collected by the researcher and kept 
in a box to which only the researcher and supervisors had access. The PSA locations were 
audited according to the above-mentioned checklist. 
5.2.4 Results 
The level of awareness of PSA among non-anaesthesiologists at CHBAH is disappointing, with 
a knowledge gap existing in both guideline and pharmacology knowledge. While certain 
professional levels and clinical departments demonstrate better knowledge than others, the 
need for PSA training is highlighted by these poor results and respondents’ indication that 
they would benefit from such training. 
Assessment of levels of comfort among PSA practitioners showed that the MO/CS/I group 
experienced lower levels of comfort, and while the overwhelming majority felt they could 
object to administering PSA if they felt uncomfortable, these doctors, once again, formed the 
largest proportion of doctors who felt they could not object.  A relationship between 
pharmacology knowledge and levels of comfort was also found, with higher scores being 
achieved by those with higher levels of comfort. 
Drugs and equipment availability was extremely variable, with trauma, department and 
surgical casualty being reasonably well equipped, and endoscopy and orthopaedic casualty 
being poorly equipped. Steps need to be taken in order to address these deficiencies in order 
to improve patient safety.  
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5.3 Limitations of the study 
The study design, sampling methodology and data collection process constitute the main 
limitations of the study. The study was contextual in nature. Specified departments at CHBAH 
were involved and thus the findings may not be generalised to other departments or 
academic hospitals in the province or country. Convenience sampling was used, particularly 
within the registrar group, and this may contribute to bias. 
The questionnaires were distributed at departmental meetings where doctors had the 
opportunity to participate. Questionnaires were collected at the end of a meeting, at 
subsequent meetings or on an individual basis. It was thus possible for participants to discuss 
answers, or check for correctness before returning the questionnaires, thereby potentially 
giving an untrue reflection of guideline awareness. In two departments, the attendance of 
meetings by the researcher was not possible, and so equal opportunity to all doctors in these 
departments could not be assured. This may explain the poor response rates. Consequently, 
limited insight into PSA practice in these departments is available. 
A self-administered questionnaire was used to assess SASA Sedation Guidelines 2010 (3) 
awareness and PSA specific knowledge. Correct answers to the questionnaire may not 
indicate awareness of the guidelines but may rather reflect a consistency between the 
guidelines and the respondents’ judgement and knowledge. Furthermore, awareness cannot 
be interpreted as use of or adherence to these guidelines. 
The study focuses on awareness of the SASA Sedation Guidelines 2010 (3), however, these are 
not the only sedation guidelines in use. Despite a small number of respondents indicating use 
of other guidelines, EMSSA, AGA and other guidelines are used and may recommend 
alternative PSA practices.  
The use of multiple-choice questions in the questionnaire may increase the measured levels 
of awareness by offering options to which respondents may have been previously unaware.  
Department heads were timeously approached for permission to conduct the study in their 
departments and were thus aware of the upcoming questionnaire and audit. This may have 
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resulted in an effort to improve guideline awareness and equipment and drug availability in 
their respective departments in anticipation of the study, and hence may not reflect reality. 
ASA practice guidelines for sedation and analgesia by non-anaesthesiologist were last updated 
in 2006. The review of these guidelines may thus be out-dated and no longer evidence-based 
practice. Despite this they have been extensively discussed in the literature review. 
5.4 Recommendations 
5.4.1 Recommendations for clinical practice 
The study may have identified a specific knowledge deficit within the departments involved 
and for this reason, may be of value to these departments and CHBAH management. The 
Department of Anaesthesiology may be in the position to assist departments in constructing a 
formal PSA training programme or may be able to offer PSA training directly. This would 
require regular review to ensure that such training has a positive impact.  
The study has also identified areas deficient of equipment and drugs required for PSA. This 
will assist departments to order the required items, and hence improve patient safety. 
5.4.2 Recommendations for further research 
Guideline adherence is a complex process, one that was not assessed in the study. Future 
research may focus on understanding the issues around this subject. 
One of the main benefits to guideline use is the positive impact on patient safety.  This study 
did not explore the occurrence of PSA-related adverse events but future research may explore 
this area. Furthermore, should PSA training be instituted, reassessment of guideline 
knowledge, levels of comfort among PSA practitioners and the potential impact on patient 
safety may be conducted. This will assist with understanding the impact of training on PSA 
practitioners as well as patients.  
Once departments have been given an opportunity to improve equipment and drug 
availability, a repeat audit may be performed in order to assess the adequacy of measures 
taken.  
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5.5 Conclusion 
The levels of awareness of PSA among non-anaesthesiologists are lacking. While guideline 
knowledge was substantially better than pharmacology knowledge, an opportunity to address 
these deficiencies exists in the form of PSA specific training. 
The equipment and drugs audit also provides detailed information about areas that need to 
be addressed in each of the PSA locations assessed. Targeted measures may thus be instituted 
in order to improve equipment and drug availability and hence patient safety.  
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Appendix 5: Information letter, questionnaire 
Dear colleague, 
Hello, my name is Karin-Ann Ben-Israel and I am an anaesthesiology registrar on the 
University of the Witwatersrand’s anaesthesiology registrar circuit.  
I would like to invite you to participate in a research study entitled: levels of awareness and 
comfort for procedural sedation and analgesia among non-anaesthesiologist. This will be 
handed in to the Wits University Department of Health Sciences as part of my MMED degree. 
The study will involve the assessment of procedural sedation and analgesia (PSA) practices at 
Chris Hani Baragwanath Academic Hospital (CHBAH). It has been observed that the 
regulations formulated by the South African Society of Anaesthesiologists (SASA) for the 
administration of PSA in adults, which ensure the safe performance of PSA, are unfamiliar to 
some health care professionals. Thus the study wishes to assess: 
 the professional levels of the doctors administering PSA 
 the locations and types of procedures being done using PSA 
 the levels of awareness amongst non-anaesthesiologists of the South African Society of 
Anaesthesiologists (SASA) Sedation Guidelines 2010 
 the levels of comfort when administering PSA.  
The study has been approved by the Human Research Ethics Committee (HREC) (Medical) 
(Number R14/49) and the Post-graduate Committee of the University of the Witwatersrand. 
Furthermore, permission to conduct the study has been obtained from the CHBAH Research 
Board and the heads of departments involved.  
Consent will be implied by agreeing to complete the questionnaire and is entirely voluntary. 
Questionnaires are not marked in any way for identification and no identifying data will be 
collected. The questionnaire should only take approximately 10 minutes to complete. Once 
completed questionnaires will be placed into a sealed box. The content of the completed 
questionnaires will only be viewed by myself and my research supervisors.   
Results published will have no identifying data and will be made available to participants.  
The study offers no benefit to participants but may result in positive changes for the future. 
Thank you for taking the time to read this letter. If you have any questions or concerns with 
regard to the study, you may contact the following people with your queries: 
 Professor Cleaton-Jones (chairperson of the HREC): 011 717 1234 
 Karin-Ann Ben-Israel (researcher): 083 329 8655.  
Please know that you are free to withdraw from the study at any time without having to 
provide a reason. The study is entirely voluntary and not taking part in it or withdrawing from 
it carries no penalty or repercussion of any sort.   
Yours sincerely 
Karin-Ann Ben-Israel  
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Appendix 6: Questionnaire 
I would like to thank you for taking the time to complete the following questionnaire. The 
questionnaire consists of five sections, and has a total of 26 questions. It should take 
approximately 10 minutes to complete. 
Instructions: Please will you complete the following questionnaire by marking the appropriate 
box with an “x”, and by filling in written responses in the space provided, where this is 
required. 
Please note: All respondents will be kept anonymous and the information kept confidential. 
Section 1: Demographics, professional level and training 
1. Gender: 
Male  
Female  
 
2. Professional level: 
Intern  
Community service  
Medical officer  
Registrar  
Consultant  
 
3. Please answer questions 3.1 or 3.2 according to your professional level. 
3.1 If you are a community service/medical officer, registrar or consultant, to which 
discipline do you belong? 
General surgery/trauma  
Orthopaedic surgery   
Emergency medicine  
Internal medicine  
Radiology  
 
 
[99] 
 
 
3.2 If you are an intern, through which disciplines have you rotated?  
General surgery/trauma  
Orthopaedic surgery   
Emergency medicine  
Internal medicine  
Obstetrics and gynaecology  
Paediatrics  
Anaesthesiology  
Family medicine  
Other  
If you have marked “other” please write down through which other disciplines you have 
rotated……………………………………………………………………………………………………………. 
4. Training post-medical degree: please mark all appropriate boxes 
Basic Life Support  
Advanced Cardiac Life Support  
PSA training, lectures/tutorials/workshops  
Other  
 
5. I would benefit from PSA training.  
Yes  
No  
Don’t know  
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Section 2: PSA procedures and locations 
1. In what locations do you perform PSA? Please mark all appropriate boxes. 
Surgical casualty  
Trauma casualty  
Upper endoscopy suite  
Lower endoscopy suite  
ERCP suite  
CT scan suite  
Interventional radiology suite  
Emergency department/casualty  
Orthopaedic casualty  
Medical casualty (Short stay ward or ward 20)  
General wards  
 
2. For what procedures do you perform PSA? Please mark all appropriate boxes. 
Incision and drainage  
Suturing  
Orthopaedic procedures  
Radiological procedures  
Endoscopy  
Intercostal drain insertion  
Cardioversion  
Other  
If you have marked other, please specify the procedures for which you have used PSA. 
…………………………………………………………………………………………………………………………………………… 
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Section 3: Guideline awareness/knowledge  
1. Is there a protocol for sedation practices in your department?  
I am not at all 
aware of them 
I have heard about 
them 
I am familiar with 
their content 
I use them when 
performing PSA 
    
 
1.1 If you are aware of a PSA protocol in your department, please indicate which protocol 
is followed. 
SASA Sedation Guidelines 2010  
Emergency Medicine Society of South Africa, Procedural sedation in the 
emergency centre 
 
American Gastroenterology Association (AGA)  
Other  
 
2. How many medical personnel are required when minimal sedation/anxiolysis is 
performed by the same doctor? Please indicate the total number of people required.  
1  
2  
3  
 
3. Which of the following are recommended by the SASA PSA guidelines before 
administering PSA? Please mark all appropriate boxes. 
A pre-sedation assessment documented in the patient file   
A pre-sedation assessment documented on a PSA assessment form  
No pre-sedation assessment is required as PSA is not general anaesthesia  
Baseline vital signs  
Ensure the patient is fasted for 6 hours for solids and 2 hours for clear fluids  
Ensure the patient is fasted for 4 hours for solids and 2 hours for clear fluids  
Document last oral intake and fast patient according to planned level of 
sedation planned 
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4. A non-anaesthesiologist is permitted to administer PSA to patients with an ASA 
physiological classification: Please mark all the appropriate boxes  
I II III IV V 
     
 
5. What monitoring is required when PSA is administered? Please mark all the appropriate 
boxes.  
Non-invasive blood pressure  
ECG  
Pulse oximetry  
Capnography  
Level of consciousness  by clinically means  
Airway patency and respiration  
Level of consciousness with bispectral index monitoring  
Serial arterial blood gas measurements  
 
6. Please indicate what emergency equipment and drugs that are required to be present in 
locations where PSA is administered. Please mark all appropriate boxes. 
Self-inflating resuscitation bag with reservoir  
Endotracheal tubes of various sizes  
Capnograph  
Naloxone  
Rocuronium  
N-acetyl cysteine  
Cardiac defibrillator  
Adrenaline  
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Section 4: Pharmacology 
1. Please indicate which medications you use for PSA. Please mark all appropriate boxes. 
Midazolam  
Diazepam  
Morphine  
Fentanyl  
Pethidine  
Propofol  
Ketamine  
Local anaesthetic agents  
Opiates in combination with benzodiazepines  
Local anaesthesia agents in combination with sedation  
Other  
If you have marked “other”, please specify which other medications you use for PSA. 
…………………………………………………………………………………………………………………………………………… 
2. When using more than one class of drug for PSA should one administer the medication in 
boluses or divided doses titrated to effect?  
Boluses  
Divided doses titrated to effect  
 
3. The dose of IV midazolam for PSA is: 
0.01-0.04mg/kg to 
a maximum bolus 
of 1mg 
0.05-0.1mg/kg to a 
maximum bolus of 
2mg 
0.1-0.2mg/kg to a 
maximum bolus of 
3mg 
1-2mg boluses 
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4. Midazolam produces the following side effects: please tick all appropriate answers.  
 True False Don’t know 
Loss of upper airway tone    
Respiratory depression    
Agitation/excitement    
Hypertension    
Tachycardia    
 
5. Ketamine produces the following side effects: please tick appropriate boxes. 
 True False Don’t know 
Bradycardia    
Reduction in intracranial pressure    
Increased saliva production    
Hypertension    
Emergence delirium    
 
6. Opioid-induced respiratory depression is dose-dependent. 
True  
False  
Don’t know  
 
7. The dose of naloxone is: 
0.01-0.05mg 0.5-0.8mg 0.04-0.2mg 
No defined dose: 
titrate to effect 
    
 
8. When performing PSA for painless procedures it is recommended to use opioids for their 
sedative effects.  
True  
False  
Don’t know  
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Section 5: Levels of comfort 
Please indicate your level of comfort, from very uncomfortable to very comfortable.  
1. Please rate your level of comfort when administering drugs for PSA. 
Very 
uncomfortable 
Uncomfortable Neutral Comfortable 
Very 
comfortable 
     
 
2. Please rate your level of comfort at being able to identify complications related to PSA 
Very 
uncomfortable 
Uncomfortable Neutral Comfortable 
Very 
comfortable 
     
 
3. Please rate your level of comfort at being able to manage complications related to PSA 
Very 
uncomfortable 
Uncomfortable Neutral Comfortable 
Very 
comfortable 
     
 
4. Do you feel you can object to administering PSA if you feel uncomfortable? 
Yes   
No  
Unsure  
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Appendix 7: Equipment and drugs audit checklist, SASA Sedation Guidelines 2010 (3) 
 
 
Devices to administer oxygen and assist with ventilation
Oxygen and oxygen tubing Oxygen source must be reliable and able to provide at least 90% oxygen via a self-inflating 
positive pressure delivery system at 15 l/min for at least 60 minutes
Oxygen flow regulator
Nasal prongs
Venturi masks To deliver 40% oxygen
Nebuliser and mask
Self-inflating resuscitation bag with reservoir
PEEP valve
Catheter mount
Airway devices and equipment
Face masks Selection of sizes
Laryngeal mask airways or similar supraglottic devices Sizes 3 – 5
Range of cuffed endotracheal tubes Sizes 5 – 8
Laryngoscope set Two handles with long and standard blades and spare batteries and bulbs
Water-soluble lubricant
10 ml syringe for inflation of pilot balloon
Tape or equivalent to secure endotracheal tube
Oropharyngeal airways Sizes 3 – 5
Nasopharyngeal airways Sizes 6 mm and 7 mm
Stylets/introducers Appropriately sized for endotracheal tubes
Magill forceps
Monitoring equipment
ECG monitor and cardiac defibrillator With conductive paste, chest paddles and razor
Pulse oximeter
Blood pressure monitoring device Non-invasive with appropriately sized cuffs
Stethoscope
Thermometer
Blood glucose testing device
Selection of test tubes for blood biochemistry and full blood count
Capnograph Nasal prongs with capnography line. Strongly recommended but not compulsory
Equipment with which to gain intravenous access
Gloves
Tourniquet
Sterile gauze pads
Alcohol skin wipes
Intravenous cannulae 18 – 22 gauge
Sterile needles
Assortment of syringes 1 ml – 50 ml
Sharps container
Tape or equivalent to secure intravenous cannula
Equipment for the accurate infusion of drugs and fluids
Infusion pumps Intravenous fluid administration for simple sedation
Syringe drivers Drug administration in advanced sedation
Intravenous administration sets Must be compatible with infusion pumps
Stickers for labelling syringes
Drip stands
Intravenous fluids Crystalloids and colloids
Equipment and drugs for procedural sedation and analgesia (PSA), SASA Sedation Guidelines 2010
All equipment should be checked regularly and stored in a mobile cupboard
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Hardware and miscellaneous equipment
Source of suction Including connection tubing
Suction catheters Including catheters for suctioning endotracheal tubes, and Yangkauer-type suction nozzles
Therapeutic heat source
Cardiac arrest board
Appropriate lighting
Operating surface that can be tilted
Urinary catheters
Nasogastric tubes
Means of summoning emergency assistance
South African Resuscitation Council algorithms Basic and advanced life support
Procedural documentation
Recommended emergency drugs
Naloxone
Flumazenil
Adrenaline (at least 10 ampoules)
Atropine or glycopyrrolate
Ephedrine or phenylephrine
(or other alpha-agonist)
Lignocaine
Glucose 50%
Hydrocortisone, methylprednisolone or dexamethosone
Promethazine
(or other H1-antagonist)
Nitroglycerine spray
Aspirin
Salbutamol
Suxamethonium
